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Summary 
This report: 
• summarises information Australia provided in 2013 to the Organisation for Economic 
Co-operation and Development’s (OECD) Health Care Quality Indicators (HCQI)  
2012–13 data collection 
• compares data supplied by Australia in 2013 to data Australia supplied in previous 
years, and to data reported by other OECD countries in the OECD’s Health at a glance 
2013: OECD indicators, or HAAG 2013 (OECD 2013a). 
Australia’s contribution to the HCQI project is part of its multifaceted effort to maintain and 
improve the safety and quality of health-care services in Australia.  
International data comparisons present many challenges due to the differences in data 
collection practices and data quality, and in administration and funding arrangements for 
health service delivery among countries.  
How does Australia compare on the HCQI indicators? 
The OECD HCQI indicators cover primary care, hospital acute care, mental health-care, 
cancer survival, hospital patient safety and patient experience. 
Primary care: Quality in primary care is measured by rates of avoidable hospital admissions 
for selected health conditions. In 2011, asthma and chronic obstructive pulmonary disease 
(COPD) separation rates were around 50% higher in Australia than the OECD average. 
Separation rates for diabetes in Australia were similar to or better than the OECD average.  
Hospital acute care: Australia’s rates for mortality following hospital admissions for acute 
myocardial infarction (AMI) were lower than the OECD average, but mortality rates 
following hospital admissions for haemorrhagic stroke were similar to the OECD average, 
and mortality rates for ischaemic stroke were higher. The rate of mortality following AMI 
has been falling steadily over time both in Australia and internationally, but fell faster in 
Australia than the OECD average from 2001 to 2011. 
Mental health-care: Rates of readmission for schizophrenia and bipolar disorder were higher 
in Australia than for the OECD average. 
Cancer care: From 2001–06 to 2006–11, five-year relative survival for cervical, breast and 
colorectal cancers was better in Australia than the averages for OECD countries. They 
improved slowly both in Australia and internationally.  
Hospital patient safety: Australia’s rates for indicators such as postoperative complications 
and obstetric trauma were generally higher than the 2011 OECD averages. However, it is 
likely that differences in reporting had a considerable impact. Some evidence exists that 
Australia has better patient safety monitoring and recording (and, largely, absence of 
financial disincentives connected to the reporting of data on patient safety events), which 
may increase the number of reported events.  
Patient experience: The only indicator submitted by Australia that was published in HAAG 
2013 concerned patient perceptions of the adequacy of the time a doctor had spent with them 
during a consultation. In 2011–12 in Australia, the number of people who felt that the doctor 
had always or often spent enough time with them was the same as the OECD average. 
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1 Introduction 
This report summarises the information provided by Australia in 2013 to the Organisation 
for Economic Co-operation and Development’s (OECD) Health Care Quality Indicators 
(HCQI) 2012–13 data collection. It also compares the 2013 data to data supplied in previous 
years and to data reported in the OECD’s Health at a glance 2013: OECD indicators, or HAAG 
2013 (OECD 2013a).  
Not all indicators submitted by Australia for 2013 were published in HAAG 2013 but they are 
presented here for completeness, and are compared with data published in earlier HAAG 
reports where possible.  
Australia’s participation in the OECD HCQI project is one example of activities undertaken 
in Australia to monitor the safety and quality of Australia’s health services. The focus is 
comparison of Australia with other countries, rather than comparisons within Australia, 
which is the focus of related national activities (summarised later in this chapter).  
While it is useful to compare health on an international scale, comparisons of this kind are 
complex due to the diverse nature of health-care systems, data sources and data quality 
across countries.  
What’s in this report? 
This chapter provides an introduction to the report and some background to the 
development and use of the OECD HCQIs. It also includes a brief overview of national 
activities involving the monitoring and assessment of safety and quality within the 
Australian health-care system. 
Chapter 2 provides information on the method used to calculate the OECD HCQIs and the 
data sources used. It also presents some general considerations for international comparison 
of data. 
Chapters 3–8 present the results for the indicators for Australia and compares these with 
results published in HAAG 2013 (or the 2009 or 2011 editions where appropriate): 
Chapter 3. Primary care indicators 
Chapter 4. Acute care indicators 
Chapter 5. Mental health-care indicators 
Chapter 6. Cancer care indicators 
Chapter 7. Patient safety indicators 
Chapter 8. Patient experience indicators. 
Information on the OECD HCQI specifications and technical notes is in Appendix B. 
National definitions for the terms used in this report are in the Glossary.  
Assessing the safety and quality of health-care in 
Australia 
Australia has a high-quality health-care system, delivering good health outcomes for the 
population. Against a range of health indicators, Australia compares favourably with other 
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developed countries (AIHW 2012a). Nevertheless, the safety and quality of health-care in 
Australia is of interest to health-care planners, providers and users, and efforts continue to 
maintain and improve the performance of health-care services. 
In Australia, national public reporting of aspects of the safety and quality of various 
components of the health system is undertaken under a number of nationally agreed 
arrangements.  
The national arrangements are accompanied by: 
• reporting on state and territory health services by state and territory governments and 
others 
• reporting by private organisations such as private hospital groups 
• reporting by organisations involved in accrediting health service providers 
• activities undertaken by health service providers to measure and monitor safety and 
quality internally within their organisations, with the aim of improving clinical 
outcomes and the appropriateness of services. In recent years, they have been supported 
by the Australian Commission on Safety and Quality in Health Care (ACSQHC), since 
2011 under National Health Reform Agreement arrangements. 
The national arrangements under which health-care safety and quality are monitored are 
arrangements for health performance reporting more broadly. They are the National 
Healthcare Agreement, the National Health Performance Framework, the National Health 
Reform Agreement and associated Performance and Accountability Framework, and the 
Review of Government Service Provision. The Australian Bureau of Statistics also reports on 
health-related national performance in its Measures of Australia’s Progress series of reports 
(ABS 2013). 
National Healthcare Agreement  
The National Healthcare Agreement (NHA), agreed by the Council of Australian 
Governments (COAG) in 2008 and updated in August 2011, is one of six National 
Agreements under the Intergovernmental Agreement on Federal Financial Relations. The 
objective of the NHA is to improve health outcomes for all Australians and ensure the 
sustainability of the Australian health system. 
The NHA guides the policy and reform directions toward its agreed outcomes, with 
attention to quality in primary and community health services, hospitals and aged care. 
Performance indicators are associated with each outcome to help the community assess the 
performance of governments towards achieving these outcomes. Changes in performance 
are assessed against baseline information and, for some, against defined performance 
benchmarks. Each year, the indicators are published by the COAG Reform Council (CRC) in 
its report on the NHA, comparing the performance of governments across Australia and 
over time (CRC 2013).  
The indicators related to the safety and quality of Australia’s health services include Selected 
potentially preventable hospitalisations, Potentially avoidable deaths, Healthcare associated infections, 
Unplanned hospital readmission rates, Rate of community follow up within the first seven days of 
discharge from a psychiatric admission, Patient satisfaction/ experience and Survival of people 
diagnosed with notifiable cancers. 
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The National Health Performance Framework 
The National Health Performance Framework (NHPF) was developed in 2001 by the 
National Health Performance Committee under the auspices of the Australian Health 
Ministers’ Advisory Council (NHPC 2002; AIHW 2012a). The NHPF was designed as an 
enduring framework, not linked to any particular agreement or to support performance 
reporting relating to a specific policy agenda. Instead, it serves as a general support for 
performance assessment, planning and benchmarking in the health sector. It is consistent 
with health performance frameworks used internationally (International Organization for 
Standardization 2010; OECD 2013a) and can therefore also support comparisons of 
Australia’s performance internationally. 
The NHPF provides a conceptual framework to understand and evaluate the health of 
Australians and the health system. It contains 14 dimensions grouped under three domains: 
health status, determinants of health and health system performance. The safety and 
effectiveness dimensions of the health system performance domain include the safety and 
quality indicators Selected potentially preventable hospitalisations, Survival following heart attack, 
Survival of people diagnosed with cancer, Potentially avoidable deaths, Adverse events treated in 
hospitals and Falls resulting in patient harm in hospitals. 
The AIHW is responsible for biennial reporting against the NHPF in its Australia’s health 
series of reports (AIHW 2012a), which presents the NHPF’s safety and quality and other 
indicators in the context of a wide range of information on Australia’s health status and 
health services. Statistics related to health-care safety and quality are also included in other 
more specific AIHW publications such as those focused on a type of health-care provider (for 
example, hospitals, AIHW 2013a), a type of disease or health condition (for example, 
cardiovascular disease, AIHW 2011), or the health of a population group (for example, 
Aboriginal and Torres Strait Islanders, AIHW 2014). 
National Health Reform Agreement 
The National Health Reform Agreement between the Australian Government and the state 
and territory governments aims to improve health outcomes for all Australians and enhance 
the sustainability of the Australian health system. Under the agreement, the National Health 
Performance Authority (NHPA) was established to report information on the performance of 
local health-care organisations (public and private hospitals, Local Hospital Networks and 
Medicare Locals, or primary health-care organisations) to inform consumers, empower 
clinicians and service providers to drive improvements, and increase transparency and 
accountability (NHPA 2013).  
NHPA’s public reporting is underpinned by the Performance and Accountability 
Framework (PAF) which was agreed by COAG in 2011. This Framework includes 48 
performance indicators (17 for hospitals and 31 for primary health-care organisations) under 
the domains of equity, effectiveness and efficiency. The effectiveness domain addresses the 
areas of safety and quality and includes several indicators similar to OECD’s HCQIs, for 
example In-hospital mortality rates for AMI, In-hospital mortality rates for stroke and Hospital 
readmission rates for patients discharged with schizophrenia. The data for these indicators are 
released through the NHPA’s MyHospitals and MyHealthyCommunities websites (NHPA 
2013). 
The ACSQHC also has safety and quality reporting-related roles under the Agreement, 
reporting publicly on the state of safety and quality, and formulating and monitoring safety 
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and quality standards. The Commission’s most recent report of the state of safety and quality 
was structured around three questions that reflect aspects of other performance reporting 
frameworks: Will my care be safe? Will I get the right care? Will I be a partner in my care? 
(ACSQHC 2013c). 
The ACSQHC’s work related to monitoring of health-care safety and quality includes its 
development of a succinct set of indicators—the core, hospital-based outcome indicators of 
safety and quality (CHBOI) that hospitals can use locally, at the hospital level, for 
hospital-level quality improvement purposes. They are designed to be generated by 
jurisdictions or private hospital ownership groups, and reported back to provider facilities. 
A number of jurisdictions are implementing the indicators in report–review–act–style cycles 
based on the routine supply of timely and targeted data back to hospitals (ACSQHC 2013b).  
Like the OECD indicators, some of the CHBOI specifications are based on indicators that 
were developed by the Agency for Healthcare Research and Quality (AHRQ) in the United 
States (ACSQHC 2013b). CHBOI includes indicators that overlap with concepts covered in 
the OECD HCQIs, such as In-hospital mortality for AMI and In-hospital mortality for stroke. 
Review of Government Service Provision  
The Review of Government Service Provision was established in 1993 by heads of 
government (now COAG) to provide information on the equity, efficiency and effectiveness 
of Australian government services and to promote ongoing performance improvement. 
National health performance information is released along with information on other 
government services through the publication of the annual Report on Government Services 
(RoGS). The 2014 edition of RoGS (SCRGSP 2014) included chapters on public hospitals 
(including maternity services), primary and community health, and mental health 
management.  
The RoGS publications are based on performance indicators set against a performance 
framework that depicts the review’s focus on outcomes, consistent with demand by 
governments for outcome-oriented performance information. This outcome information is 
supplemented by information on outputs, grouped under ‘equity’, ‘effectiveness’ and 
‘efficiency’ headings (SCRGSP 2014). Safety and quality performance indicators were 
included within the ‘effectiveness’ grouping.  
OECD’s health care quality indicators  
The OECD’s Health Care Quality Indicator (HCQI) project is an international project aimed 
at developing a common set of indicators about the quality of health-care delivered across 
OECD member countries, for reporting at a national level for international comparison. The 
HCQI project began in 2002 with the development of a conceptual framework for measuring 
HCQIs and associated research on international health performance frameworks (Arah et al. 
2006). Work since 2002 has seen the development and continued expansion of a set of 
indicators that support international comparisons of the quality of health-care. The 
indicators cover domains of health status, determinants of health, health-care activities and 
health expenditure and financing. 
After initial testing of a set of indicators and extensive investigations of their comparability, 
the publication of a chapter on quality of care was included in the OECD’s Health at a glance 
2007. Since then, the biennial publication of a chapter in Health a glance has been one of the 
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main outputs of the HCQI work. The OECD also publishes the data it collects for the HCQI 
data collection in its online statistical database: OECD.StatExtracts (OECD 2013b). 
Research and development work to expand OECD’s health-care quality reporting is ongoing, 
with the indicator set expanding to incorporate new indicators. In 2011, the 2010–11 HCQI 
data collection contained 40 indicators covering acute care, primary care, mental health-care, 
cancer care and patient safety. The 2012–13 HCQI (for HAAG 2013) data collection included a 
total of 75 indicators, covering acute care, primary care, mental health-care, cancer care, 
patient safety and patient experience. Sixty of the 2013 HCQIs were calculated using data 
submitted by OECD member countries; the remaining 15 indicators were collected 
separately by the OECD. 
Australia’s HCQI submissions 
Australia has contributed data to the OECD’s HCQI project since 2009. In 2011, data for 20 of 
40 HCQIs were submitted calculated using 2008–09 data from the National Hospital 
Morbidity Database. In 2013, Australia submitted data for 33 of the 60 HCQIs requested from 
countries; 28 were prepared by the AIHW and 5 were prepared by the Australian Bureau of 
Statistics (ABS), for the reference period of 2011–12. The AIHW also provided some 
additional back-casted data in the 2013 submission, where available. 
Some differences in data may affect comparability of the indicators from the different OECD 
countries. Details of issues with preparation of the indicators are noted along with 
presentation of the indicators in the relevant chapters of this report. 
Australia was not able to provide a number of HCQIs in 2013 for a range of reasons. 
Australia does not currently collect the data to calculate some indicators and therefore would 
have required more lead time and/or resources for data collation than was available. For 
example: 
• Annual retinal exam for diabetics data were not available. 
• Data were not available for the patient experience indicators that were not submitted. 
• Indicators that aimed to measure mortality after discharge from hospital were not 
available, as linkage of hospital and mortality data is not possible, routinely.  
• Indicators for readmissions to any hospital (rather than to the same hospital) could not 
be prepared as individual patient records cannot be routinely linked in the national 
hospital data collections.  
• Data on Inpatient suicides were not available as there is no agreed Australian method for 
the collection and reporting of these data. 
Table 1.1 lists the HCQIs and shows those for which Australia submitted data in 2013. 
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Table 1.1: OECD health care quality indicators 2012–13  
Indicator 
Included in Australia’s data 
submission in 2013 
Primary care  
Asthma hospital admission  
Chronic Obstructive Pulmonary Disease (COPD) hospital admission  
Congestive Heart Failure (CHF) hospital admission  
Hypertension hospital admission  
Uncontrolled diabetes without complications hospital admission  
Diabetes short-term complications hospital admission  
Diabetes long-term complications hospital admission  
Diabetes lower extremity amputation  
Annual retinal exam for diabetics x 
Acute care   
Patient-based acute myocardial infarction (AMI) 30 day (in-hospital and out of hospital) mortality x 
Patient-based AMI 30 day in-hospital (any hospital) mortality x 
Admission-based AMI 30 day in-hospital mortality  
Patient-based haemorrhagic stroke 30 day (in-hospital and out of hospital) mortality x 
Patient-based haemorrhagic stroke 30 day in-hospital (any hospital) mortality x 
Admission-based haemorrhagic stroke 30 day in-hospital mortality  
Patient-based ischemic stroke 30 day (in-hospital and out of hospital) mortality x 
Patient-based ischemic stroke 30 day in-hospital (any hospital) mortality x 
Admission-based ischemic stroke 30 day in-hospital mortality  
Hip fracture surgery initiated within 48 hours after admission to the hospital x 
Mental health-care  
Any hospital readmissions within 30 days for patients discharged with schizophrenia x 
Same hospital readmissions within 30 days for patients discharged with schizophrenia  
Any hospital readmission within 30 days among patients discharged with schizophrenia x 
Same hospital readmission within 30 days among patients discharged with schizophrenia  
Any hospital readmissions within 30 days for patients discharged with bipolar disorder x 
Same hospital readmissions within 30 days for patients discharged with bipolar disorder  
Any hospital readmission within 30 days among patients discharged with bipolar disorder x 
Same hospital readmission within 30 days among patients discharged with bipolar disorder  
In-patient suicides among people diagnosed with a mental disorder x 
In-patient suicides among people diagnosed with schizophrenia or bipolar disorder x 
Deaths after discharge from suicide among people diagnosed with a mental disorder x 
Deaths after discharge from suicide among people diagnosed with schizophrenia or bipolar disorder x 
Excess mortality for patients with schizophrenia x 
Excess mortality for patients with bipolar disorder x 
 (continued) 
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Table 1.1 (continued): OECD health care quality indicators 2012–13 
Indicator 
Included in Australia’s data 
submission in 2013 
Cancer care  
Breast cancer five-year relative survival  
Cervical cancer five-year relative survival  
Colorectal cancer five-year relative survival  
Patient safety  
Retained surgical item or unretrieved device fragment  
Accidental puncture or laceration  
Postoperative haemorrhage or haematoma  
Postoperative wound dehiscence  
Postoperative pulmonary embolism or deep vein thrombosis—all surgical discharges  
Postoperative pulmonary embolism or deep vein thrombosis—hip and knee replacement discharges  
Postoperative sepsis—all surgical discharges  
Postoperative sepsis—abdominal surgery discharges  
Obstetric trauma vaginal delivery with instrument  
Obstetric trauma vaginal delivery without instrument  
Patient experience  
Waiting time of more than 4 weeks for getting appointment with a specialist x 
Waiting time of more than 1 hour on the day of consultation with a doctor x 
Consultation skipped due to difficulties in travelling  
Consultation skipped due to costs  
Medical tests, treatment or follow-up skipped due to costs  
Prescribed medicines skipped due to costs  
Doctor spending enough time with patients during the consultation  
Regular doctor spending enough time with patients during the consultation x 
Doctor providing easy-to-understand explanations x 
Regular doctor providing easy-to-understand explanations x 
Doctor giving opportunity to ask questions or raise concerns x 
Regular doctor giving opportunity to ask questions or raise concerns x 
Doctor involving patients in decisions about care or treatment x 
Regular doctor involving patients in decisions about care or treatment x 
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2 Methods and data sources 
This chapter presents information about the specifications and data sources for the HCQIs. It 
also includes information on broad issues affecting the comparability of Australia’s data with 
those of other OECD member countries. More specific guidance on the comparability of 
Australian HCQI data is also included at the ends of chapters 3 to 8.  
In 2013, the AIHW and the ABS provided data for 33 of the 60 OECD HCQIs where 
comparability and quality was considered sufficient. The HCQIs include a number of 
indicators not supported by current Australian collection arrangements, as noted in 
Chapter 1.  
The acute care, primary care, mental health-care and patient safety HCQIs were reported 
using 2011–12 data from the National Hospital Morbidity Database (NHMD) at the AIHW. 
Where possible, data for earlier years were also supplied to provide time series for trend 
analysis. The specific years supplied are noted for each HCQI in chapters 3 to 8.  
Data for the cancer care indicators were sourced from the Australian Cancer Database (ACD) 
at the AIHW. 
Patient experience data were sourced from the 2011–12 ABS Patient Experience Survey. 
Specifications for the HCQIs 
In preparing data for the HCQIs, the AIHW adhered as closely as possible to the OECD 
specifications in the OECD guidelines and technical manual for the HCQIs provided to the 
AIHW by the OECD. These are reproduced in brief at Appendix B (and available on request 
from the AIHW). 
The guidelines and technical manual for the HCQIs outline key concepts underpinning the 
preparation of the HCQIs. Where relevant, these concepts are noted throughout this report, 
particularly if Australian data collection and reporting practices deviate from those specified 
by the OECD. The technical manual lists ICD-9-CM (US version) and ICD-10 (2010 WHO 
version) codes and outline steps required to convert codes supplied in the specifications to 
each country’s version of ICD or procedure codes. Age ranges and sex requirements for each 
HCQI are also included in these specification documents. 
In line with OECD specifications, Australia provided confidence intervals for the HCQIs, 
where required. Confidence intervals have been included in this publication only for data 
sourced from survey data; that is, only the patient experience data. They have not been 
provided for indicators based on the NHMD and ACD. This approach was taken because, in 
the case of data collected by way of a sample survey, confidence intervals represent the 
sampling error. That is, the uncertainty of the quantity being reported arises from estimating 
a value for a population, based on data from a sample of that population. This theory is well 
developed and longstanding and therefore confidence intervals are considered reliable. For 
data from the NHMD and the ACD, which are collations of records of all relevant events 
rather than a sample, it is very difficult to determine the cause and properties of variability 
and therefore construct ‘correct’ or meaningful confidence intervals. Therefore the AIHW 
considers that confidence intervals created for such sources would be of uncertain reliability. 
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Data sources for the HCQIs 
As noted above, the data provided for HCQIs by the AIHW and ABS were sourced from 
three national data collections. Information on each of these collections is provided below.  
National Hospital Morbidity Database 
The NHMD is a comprehensive dataset that has records for separations of admitted patients 
from essentially all public and private hospitals in Australia. The NHMD is based on the 
standards set out in the Admitted Patient Care National Minimum Data Set (APC NMDS).  
It provides for recording of a principal diagnosis and up to 99 additional diagnoses.  
The counting unit in the NHMD is the separation. ‘Separation’ refers to the episode of 
admitted patient care (see Separation in the Glossary). This can be a total hospital stay (from 
admission to discharge, transfer or death) or a portion of a hospital stay beginning or ending 
in a change of type of care (for example, from acute care to rehabilitation). When interpreting 
data from the NHMD, it is worth noting that data on hospital activity are affected by changes 
in coverage, administrative and reporting arrangements over time. Separations with a care 
type of Newborn with no qualified days and records for Hospital boarders and Posthumous 
organ procurement have been excluded. 
It should be noted that data from the AIHW’s NHMD are collected primarily for the 
purposes of recording care provided to admitted patients. Use for purposes such as 
reporting the OECD HCQIs has not been validated for accuracy in Australia. The results 
prepared using data from the NHMD should therefore be treated with caution.  
AIHW notes a variation in Australia’s mechanism for identifying same-day separations 
when providing data, although it is considered unlikely to affect comparability. The NHMD 
does not hold information on time of admission or separation, so a length of stay (LOS) of 
less than 24 hours cannot be accurately identified. A same-day flag identifies separations 
where a patient was discharged from hospital on the same calendar day during which they 
were admitted. Such separations were used as a proxy for separations with an LOS of less 
than 24 hours.  
Patient days are calculated as the difference between admission and separation dates, less 
leave days if any, or one, depending on which was greater. Patient days were used to 
calculate LOS <4 days, <3 days and <2 days. This does not perfectly capture the concept in 
all cases, but was the best available option. 
Diagnoses and procedures are recorded in the NHMD using the International Statistical 
Classification of Diseases and Related Health Problems, Tenth revision, Australian 
Modification (ICD-10-AM) or the Australian Classification of Health Interventions (ACHI), 
as appropriate. 
The data quality statement for the NHMD is at Appendix A. 
Australian Cancer Database 
The ACD is a collection of data on all primary malignant cancers diagnosed in Australia 
since 1982. The following exclusions apply to the ACD: 
• Tumours diagnosed as benign, of borderline malignancy or in situ are not included. 
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• Only the first occurrence of a cancer is included. That is, recurrences and metastases are 
not included. 
Australian cancer data are primarily coded using the World Health Organization’s 
classification for coding the topography and the morphology of the neoplasm, the 
International Classification of Diseases for Oncology 3rd edition (ICDO-3). However, disease 
codes are ICD-10 codes. 
The ACD is routinely linked to the AIHW’s National Death Index (NDI) so that cancer data 
can be updated with information on deaths of people who have been reported with cancer. 
The NDI is a database of all deaths that have occurred in Australia since 1980 and is 
maintained by the AIHW for the purposes of record linkage. At the time of analysis, cancer 
cases had been followed for deaths (from any cause) to the end of 2010. 
The data quality statement for the ACD is at Appendix A. 
ABS Patient Experience Survey 
The ABS Patient Experience Survey is conducted annually and collects national data on 
respondents’ perceptions of access and barriers to a range of health-care services. Data are 
also collected on aspects of communication between patients and health professionals  
(ABS 2012).  
The Patient Experience Survey has been conducted by the ABS throughout Australia from 
July to June each year since 2010–11, as a topic on the ABS Multipurpose Household Survey.  
After taking into account sample loss, the response rate for the Patient Experience Survey in 
2011–12 was 79.6%. In total, information was collected from 26,437 fully responding 
households. One person aged 15 or over from each household was asked questions in 
relation to their own health. If the randomly selected person was aged 15 to 17 years, 
permission was sought from a parent or guardian before conducting the interview. For 334 
people aged 15 to 17 years, permission was not given and the parent or guardian was asked 
the questions. 
A data quality statement for the 2011–12 Patient Experience Survey is available online at 
<www.abs.gov.au>. 
Methodological issues for the indicators 
The OECD specifications were followed as closely as possible in the preparation of 
Australia’s indicator data. Some specific points to note in relation to the indicator groups are 
outlined below. An overarching terminological issue is important to note: where indicators 
refer to a ‘discharge’ or an ‘admission’ in the OECD specifications, the similar, but not 
identical concept ‘separation’ is used by Australia (see Separation in the Glossary).  
The HCQIs were originally written to use the ICD-9-CM coding/classification system (used 
in the United States). In developing the specifications, ICD-9-CM diagnosis codes were then 
mapped by the OECD to ICD-10 codes for use in other countries. These ICD-10 codes were 
mapped by the AIHW to ICD-10-AM; see Appendix B for details. Any cases where 
differences between ICD-10 and ICD-10-AM were substantial are noted in chapters 3 to 8. 
Caution is advised when comparing data across years due to changes between the  
ICD-10-AM 5th edition (used in 2007–08), the ICD-10-AM 6th edition (used in 2008–09 and 
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2009–10) and ICD-10-AM 7th edition (used in 2010–11 and 2011–12) and their associated 
Australian Coding Standards. 
As there is no common international classification of medical procedures, the OECD 
specifications provide ICD-9-CM (United States version) procedure codes to define 
inclusions or exclusions to the numerator, denominator, or both, for some indicators. These 
ICD-9-CM codes were mapped by the AIHW to codes in ACHI for the relevant years to 
calculate the Australian results. While ICD-9-CM to ACHI mapping is not straightforward in 
all cases, no significant mapping issues were encountered for procedure codes used in the 
HCQIs. See Appendix B for details. 
HAAG 2013 notes issues with comparability for each group of indicators. This is referenced 
in this publication. 
All OECD HCQIs that refer to admissions are, within the Australian context, in fact 
separations and therefore are referred to as such in this publication.  
Primary care 
For each of the primary care indicators, the denominator required is the population count. 
For the 2011–12 data, the population used is the preliminary estimated resident population 
as at 30 June 2012 (as published by the ABS in the Australian Demographic Statistics series). 
For earlier years, the population used is the preliminary rebased estimated resident 
population as at 30 June in the relevant year. Refer to the ABS Australian Demographic 
Statistics series for further details about population estimation. 
Acute care 
For acute care indicators, numbers were provided for males and females as per OECD 
specifications. Therefore patients were excluded from the calculation if their sex was 
categorised as ‘indeterminate’ or ‘not stated/inadequately described’. These exclusions were 
made both in the numerator and the denominator. 
Mental health-care 
Linking of episodes of care within the same hospital is possible for some public hospitals 
within the NHMD. Seven jurisdictions approved the linkage of episodes of care within the 
same hospital for the mental health readmission indicators. Western Australia did not. While 
public hospitals provide the majority of mental health-related separations (AIHW 2013b), the 
exclusion of data from Western Australia and from private hospitals means that the mental 
health readmission indicators are based on an incomplete set of the Australian separation 
data for mental health conditions. 
Cancer care 
Results for the cancer care HCQIs were calculated from the ACD in 6-year follow-up periods 
from 1995–2000 to 2005–2010. Note that the OECD HCQI project refers to these survival data 
as 5-year relative survival rates. In the Australian context, the reference periods prescribed by 
the OECD, for example 2000 to 2005, would generally be described as relating to 6-year 
survival.  
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Patient safety 
Patient safety indicators supplied to the OECD for the HCQIs data collection were crude 
rates, with age-sex standardisation done by the OECD once all data were collected. This was 
because the OECD method for age-sex standardising for patient safety indicators was to 
aggregate specific denominator counts provided by each country to produce an internal 
standard population that was used along with each country’s age-sex group indicator rate to 
form direct age-sex standardised rates. The crude rates supplied for Australia are presented 
in this report. 
Patient experience 
For the patient experience HCQIs, results were calculated by the ABS using data from the 
2011–12 Patient Experience Survey.  
HCQI specifications for the denominator of the patient experience indicators required both 
weighted and unweighted counts from survey data. Australia was unable to provide the 
denominator unweighted as the ABS does not release that information.  
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3 Primary care indicators 
This chapter presents data for the primary care indicators supplied for Australia to the 2013 
HAAG HCQI data collection. It compares these data with the HCQI results for OECD 
countries published in HAAG 2013, and comments on international comparability. 
The OECD HCQIs for primary care include rates of avoidable hospital admissions for a 
range of conditions. Rates of avoidable hospital admissions serve as measures of the 
effectiveness of the primary health-care system, as access to ‘a high performing primary 
health-care system can, to a significant extent, avoid acute deterioration in people living with 
[these conditions] and prevent their admission to hospital’ (OECD 2013a). 
The AIHW supplied 8 primary care indicators for the 2013 HAAG data submission, based on 
2007–08 to 2011–12 NHMD data. The indicators requested by the OECD were for avoidable 
hospital admission rates, but, as noted in the chapter on methods, Australia uses the similar 
concept of ‘separation’. Therefore the indicators supplied were rates for:  
• Asthma hospital separation 
• Chronic obstructive pulmonary disease (COPD) hospital separation 
• Congestive heart failure (CHF) hospital separation 
• Hypertension hospital separation 
• Uncontrolled diabetes without complications hospital separation 
• Diabetes short-term complications hospital separation 
• Diabetes long-term complications hospital separation 
• Diabetes lower extremity amputation.  
The National Healthcare Agreement includes an indicator of Selected potentially preventable 
hospitalisations, which reports on separations from hospital that could have potentially been 
prevented through the provision of appropriate non-hospital health services. This indicator 
includes separations for the conditions listed above. 
For details of the methods used for calculating the indicators in this chapter see Chapter 2.  
3.1  Asthma hospital separation  
In 2011–12, the asthma separation rate for people aged 15 and over in Australia was 69 per 
100,000 population, about the same as rates for each year since 2007–08. Rates for females 
were more than twice those for males (40 separations for males and 95 for females per 
100,000 population in 2011–12), with this difference consistent over time (Table 3.1).  
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Table 3.1: Number of asthma separations for people aged 15 and over, 
per 100,000 population, by sex, Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 40.8 100.4 71.9 
2008–09 37.4 92.4 66.2 
2009–10 39.1 97.0 69.2 
2010–11 41.3 92.6 68.1 
2011–12 39.7 95.3 68.8 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
3.2  Chronic obstructive pulmonary disease hospital 
separation  
The rate of COPD separations for people aged 15 and over in Australia was between 309 and 
325 per 100,000 in each year between 2007–08 and 2011–12. Rates were higher for males than 
females in each year (Table 3.2). 
Table 3.2: Number of COPD separations for people aged 15 and over,  
per 100,000 population, by sex, Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 390.5 277.1 319.8 
2008–09 385.4 290.0 324.7 
2009–10 367.2 276.4 309.7 
2010–11 375.1 284.4 317.0 
2011–12 373.7 288.5 319.3 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
3.3 Congestive heart failure hospital separation  
The CHF separation rate for people aged 15 and over in Australia was 234 per 100,000 
population in 2011–12, with little change since 2007–08. Rates for males are about one-third 
higher than for females, a trend that is stable over the reported period (Table 3.3). 
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Table 3.3: Number of CHF separations for people aged 15 and over,  
per 100,000 population, by sex, Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 285.1 197.8 234.4 
2008–09 277.6 193.3 228.2 
2009–10 270.3 184.4 219.8 
2010–11 294.2 197.4 237.2 
2011–12 289.3 195.2 233.8 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
3.4 Hypertension hospital separation  
The Hypertension hospital separation rate for people aged 15 and over in Australia was 36 per 
100,000 population in 2011–12, up from almost 30 in 2007–08. Rates are about 60% higher for 
females than males (Table 3.4). 
Table 3.4: Number of hypertension separations for people aged 15  
and over, per 100,000 population, by sex, Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 20.6 35.3 29.4 
2008–09 20.1 34.0 28.5 
2009–10 20.5 35.3 29.4 
2010–11 23.9 40.5 33.9 
2011–12 26.0 41.4 35.6 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
3.5 Diabetes hospital separations  
Caution should be used when comparing data over the period reported due to coding 
changes (explained in Chapter 2: Methods and data sources) that resulted in decreased 
reporting of additional diagnoses for diabetes, particularly between 2009–10 and 2010–11. 
Uncontrolled diabetes without complications hospital separation  
This indicator includes separations where diabetes was the principal diagnosis without 
mention of short or long-term complications. The rate of Uncontrolled diabetes without 
complications separations in Australia was between 6.4 and 7.4 per 100,000 population 
between 2007–08 and 2011–12. At almost 60% of separations, rates for males were 
consistently higher than those for females (Table 3.5).  
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Table 3.5: Number of uncontrolled diabetes without complications 
separations for people aged 15 and over, per 100,000 population, by 
sex, Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 7.3 5.5 6.4 
2008–09 8.5 6.4 7.4 
2009–10 8.4 5.8 7.1 
2010–11 8.4 5.6 6.9 
2011–12 8.4 6.3 7.2 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
Diabetes short-term complications hospital separation  
Rates of people aged 15 and over in Australia with Diabetes short-term complications 
apparently rose from 22 in 2007–08 to 27 separations per 100,000 population in 2011–12. The 
rates, which include conditions such as ketoacidosis and hyperosmolarity (see Appendix B), 
were similar for males and females (Table 3.6). 
Table 3.6: Number of diabetes short-term complications separations 
for people aged 15 and over, per 100,000 population, by sex, 
Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 21.7 21.7 21.7 
2008–09 23.1 23.4 23.2 
2009–10 22.9 24.2 23.5 
2010–11 23.8 24.3 24.0 
2011–12 27.2 27.8 27.4 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
Diabetes long-term complications hospital separation  
Diabetes long-term complications include complications related to the kidneys, eyes, brain, 
circulatory system and other selected long-term complications (see Appendix B). In 2011–12 
the separation rate was 97 per 100,000 population. This rate has more than halved since 
2007–08, but this change is likely to be due primarily to changes in diabetes coding 
standards. Rates for females were much lower than for males, with 60–62% of separations 
attributed to males over the reporting period (Table 3.7). 
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Table 3.7: Number of diabetes long-term complications separations 
for people aged 15 and over, per 100,000 population, by sex, 
Australia, 2007–08 to 2011–12 
Year Male Female Total 
2007–08 253.1 166.6 204.6 
2008–09 255.0 166.1 205.1 
2009–10 244.3 154.9 194.0 
2010–11 130.8 79.3 102.1 
2011–12 124.1 76.1 97.3 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
Diabetes lower extremity amputation  
In 2011–12, the separation rate for Diabetes lower extremity amputation was 4.6 per 100,000 
population, down from 6.9 in 2007–08. This rate excludes minor amputations of the toes, as 
they may be a result of improved patient surveillance and early detection of conditions that 
could otherwise require major amputations (OECD 2009). Rates for males were around three 
times as high as for females (7.4 and 2.4 separations respectively in 2011–12) (Table 3.8). 
Table 3.8: Number of diabetes lower extremity amputation 
separations for people aged 15 and over, per 100,000 population, by 
sex, Australia, 2007–08 to 2011–12  
Year Male Female Total 
2007–08 11.1 3.6 6.9 
2008–09 10.2 3.3 6.4 
2009–10 8.8 2.9 5.5 
2010–11 8.2 2.5 5.0 
2011–12 7.4 2.4 4.6 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2007–08 to 2011–12. 
3.6 How does Australia compare internationally? 
For each of the primary care HCQIs reported by the OECD in HAAG 2013, rates were 
reported for adults (aged 15 and over) for 2006 and 2011, or the nearest years provided by 
OECD member countries. For Australia the data published by the OECD were for the  
2007–08 and 2010–11 financial years.  
HAAG 2013 notes that ‘differences in coding practices among countries and the definition of 
an admission may affect the comparability of data. Differences in disease classification 
systems, for example between ICD-9-CM and ICD-10-AM, may also affect data 
comparability’. 
Rates reported in HAAG 2013 were for avoidable admissions for asthma, COPD and 
diabetes, and were age-sex standardised to the 2010 OECD population aged 15 and over, as 
presented here.  
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The OECD did not publish Congestive heart failure (CHF) hospital separation, Hypertension 
hospital separation or Diabetes lower extremity amputation in HAAG 2013. However, Congestive 
heart failure (CHF) hospital separation and Diabetes lower extremity amputation are listed on 
OECD.StatExtracts (OECD 2013b). 
Mappings from OECD specifications to classifications used in Australia resulted in a number 
classification issues for the primary care indicators which may affect comparability between 
countries: 
• For 2 indicators (CHF hospital separation and Hypertension hospital separation) cardiac 
procedure codes were also required for the indicator calculation. These were mapped by 
AIHW from ICD-9-CM to equivalent codes in ACHI, but the mapping was not exact. See 
Appendix B.  
• For Uncontrolled diabetes separation rate the ICD-9-CM codes in the specifications address 
the concept of uncontrolled diabetes, while the mapped ICD-10 codes do not cover the 
exact concept. 
• Caution must be taken when interpreting the COPD and Asthma separation rate 
indicators, as the mapped ICD-9-CM and ICD-10 codes do not measure identical 
concepts in relation to acute bronchitis.  
• Caution should be used when comparing diabetes data from 2007–08 through to 2011–12 
because of changes between ICD-10-AM 5th, 6th and 7th editions and their Coding 
Standards which resulted in decreased reporting of additional diagnoses for diabetes. 
Asthma hospital separation  
In 2010–11, Australia’s rate was 68 separations per 100,000 population, almost 50% higher 
than the OECD average of 46. Asthma separation rates have fallen in Australia since 2007–08, 
from 72 per 100,000 population; however, the OECD average also fell, from 55 in 2006 
(OECD 2013a). Asthma rates in 2011, for the 26 countries that reported Asthma hospital 
separation rates in HAAG 2013, ranged from a low of 11.4 in Italy to more than 150 in the 
Slovak Republic. 
Chronic obstructive pulmonary disease hospital separation  
In 2010–11, Australia’s rate was 317 separations per 100,000 population, more than 56% 
higher than the OECD average. The average COPD separation rates have not changed 
substantially in Australia over the reported period, but the OECD average fell from 223 in 
2006 to 203 in 2011 (OECD 2013a). A total of 26 countries contributed rates of COPD to 
HAAG 2013; the lowest rate of COPD hospital separation in 2011 was in Japan (23.5) and the 
highest was in Hungary where the rate of admissions was almost 380. 
Congestive heart failure hospital separation  
OECD.StatExtracts (OECD 2013b) includes rates for 30 OECD countries for Congestive heart 
failure hospital separation in 2011. These range from 57 per 100,000 population in Slovenia to 
almost 470 in Hungary. AIHW analysis of these data shows that Australia’s rate—233—is 
similar to the average of the 21 countries that provided data in 2011.  
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Hypertension hospital separation  
Hypertension separation rates were last included in HAAG 2009. Australia’s rate was 28 per 
100,000 population, 67% lower than the 2007 OECD average of 84 (OECD 2009). 
Diabetes hospital separations  
Diabetes is an area where mapping between ICD-9-CM and ICD-10-AM can be a 
complicated task as both the ICD and coding standards changed substantially over time. 
Diabetes indicators are likely to be subject to variations across countries with different 
practices for recording diabetes as either a primary or additional diagnosis. These variations 
affect the comparability of results. They are currently under investigation by an OECD HCQI 
Expert Group.  
The OECD arrived at the results for Diabetes hospital separation published in HAAG 2013 by 
summing the age-standardised rates for Diabetes short-term complications, Diabetes long-term 
complications and Uncontrolled diabetes without complications. Data for diabetes separations 
were also available broken down by ‘with complications’ and ‘without complications’. The 
data for Diabetes with complications were arrived at by summing Diabetes short-term 
complications and Diabetes long-term complications. 
In 2011–12, Australia’s separation rate for Diabetes with complications was 126 per 100,000 
population, down from 226 in 2007–08. However, some of this decrease would have been 
caused by changes in diabetes coding standards that led to decreased reporting of additional 
diagnoses for diabetes. The OECD average also improved over this time (119 in 2011 down 
from 134 in 2006) (OECD 2013a). 
The rates for Diabetes without complications were substantially lower in Australia in both 2006 
and 2011—6.4 and 6.9 separations per 100,000 population respectively, where the OECD 
averages were 55 and 45 respectively (OECD 2013a).  
Diabetes hospital separation rates (which are the sum of the 2 indicators above) in 2011 were 
133 in Australia compared with the OECD average of 164 per 100,000 population. For 2011, 
22 countries reported Diabetes hospital separations rates in HAAG 2013. Of these the lowest 
rates were reported in Italy and the highest was in Hungary (54 compared with 404 
admissions per 100,000 population). 
Diabetes lower extremity amputation is reported in OECD.StatsExtracts (OECD 2013a). The rate 
in 2011 ranged from 1.1 per 100,000 population in Hungary to 18.4 in Germany. The AIHW 
calculated that the average for the 18 countries that supplied data in 2011 was 7.8. Australia’s 
rate was 5.0. 
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4 Acute care indicators 
This chapter presents data for the acute care indicators supplied for Australia to the 2013 
HAAG HCQI data collection. It compares these data with the HCQI results for OECD 
countries published in HAAG 2013, and comments on international comparability. 
Australia calculated and submitted 3 acute care indicators as part of its data submission to 
the OECD in 2013. The OECD specifications request admission-based data but Australia has 
supplied separations data as explained in Chapter 2. The indicators are rates for: 
• Separation-based AMI 30-day in-hospital mortality  
• Separation-based haemorrhagic stroke 30-day in-hospital mortality 
• Separation-based ischaemic stroke 30-day in-hospital mortality. 
These indicators measure the proportion of total separations where the patient died in the 
same hospital, during that same episode of care, within 30 days of admission. In-hospital 
mortality rates for acute myocardial infarction (AMI) and stroke may reflect the quality of 
care provided for those conditions (OECD 2011).  
These indicators have been prepared for the years 2008–09 to 2011–12. ICD-10-AM diagnosis 
codes used for indicator calculation are considered appropriate for use and consistent in 
meaning for the reference years reported (see Appendix B for specifications for acute care 
indicators). Rates are age-sex standardised, but are not risk-adjusted for any other patient 
characteristics. 
4.1  Separation-based AMI 30-day in-hospital 
mortality 
Table 4.1 presents Australia’s results for Separation-based AMI 30-day in-hospital mortality rate 
per 100 separations from 2008–09 to 2011–12, by sex. The rate fell steadily between 2008–09 
and 2011–12 by almost 20%, from 3.3 deaths per 100 separations in 2008–09 to 2.7 in 2011–12. 
In 2011–12 the mortality rate was similar for females and males. 
Table 4.1: Separation-based AMI 30-day in-hospital mortality for 
people aged 15 and over, deaths per 100 separations, by sex, 
Australia, 2008–09 to 2011–12  
Year Male Female Total 
2008–09 3.22 3.39 3.30 
2009–10 3.00 3.46 3.24 
2010–11 3.02 3.06 3.04 
2011–12 2.67 2.72 2.70 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2008–09 to 2011–12. 
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4.2  Separation-based stroke 30-day in-hospital 
mortality 
The mortality rate for stroke in Australia has fallen over several decades due to a variety of 
factors, such as reduction in risk factors such as tobacco smoking and high blood pressure 
(AIHW 2012a) and improved treatments (OECD 2013a).  
From 2008–09 to 2011–12, the number of deaths in Australia that occurred in the same 
hospital, within 30 days of the hospital admission, with a primary diagnosis of haemorrhagic 
stroke was about 3 times than for ischaemic stroke (tables 4.2 and 4.3).  
Haemorrhagic stroke 
Table 4.2 shows the Separation-based haemorrhagic stroke 30-day in-hospital mortality rate per 100 
separations from 2008–09 to 2011–12, by sex. The rate was relatively unchanged over the 
reported period at around 17 deaths per 100 separations. The mortality rates for females 
were slightly higher than for males. 
Table 4.2: Separation-based haemorrhagic stroke 30 day in-hospital 
mortality for people aged 15 and over, deaths per 100 separations, 
by sex, Australia, 2008–09 to 2011–12 
Year Male Female Total 
2008–09 16.92 17.48 17.33 
2009–10 15.00 17.36 16.31 
2010–11 15.72 19.47 17.80 
2011–12 16.33 17.21 16.90 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2008–09 to 2011–12. 
Ischaemic stroke 
Table 4.3 shows the Separation-based ischaemic stroke 30 day in-hospital mortality rate per 100 
separations from 2008–09 to 2011–12, by sex. Over this period the rate was between 5.2 and 
5.8 per 100 separations. Rates were similar for males and females. 
Table 4.3: Separation-based ischaemic stroke 30 day in-hospital 
mortality for people aged 15 and over, deaths per 100 separations, 
by sex, Australia, 2008–09 to 2011–12  
Year Male Female Total 
2008–09 6.03 5.49 5.79 
2009–10 5.27 5.58 5.47 
2010–11 5.03 5.82 5.50 
2011–12 4.73 5.58 5.21 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2008–09 to 2011–12. 
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4.3 How does Australia compare internationally? 
The most recent data reported in HAAG 2013 are not the most recent data available in 
Australia (2011–12 data for Australia are reported above), but the year nearest to the OECD 
reported year, 2011. In Australia, this was 2010–11.  
The HAAG 2013 presents admission rates for the population aged 45 and over (presented 
below). Australia supplied an all-ages rate (presented above).  
In Australia, the NHMD can be used to calculate separation-based same-hospital mortality, 
but not patient-based same-hospital mortality nor patient-based any-hospital mortality, nor 
patient-based in- or out-of hospital mortality at the national level. This means the Australian 
data can identify if a patient dies during a single episode of care in one hospital. However, if 
a patient was discharged from hospital or had a change in care type, then returned to that 
same hospital or another hospital and died, or died out of hospital, all within 30 days, that 
death would not be counted by this indicator. While it is possible to link patient records 
within the same hospital for public hospitals, it is not currently possible to link a patient’s 
episodes of care in the data at a national level between hospitals. Nor is it possible to link 
hospital records to deaths records at the national level. The indicators therefore 
underestimate true case fatality. 
Separation-based AMI 30-day in-hospital mortality  
HAAG 2013 reported data for adults aged 45 and over from 2001, 2006 and 2011. Rates in 
Australia fell over time, consistent with the general trend seen in most OECD countries. This 
reflects improvements in hospital care for AMI—for example, the increased and more timely 
use of new hospital-based cardiac procedures such as percutaneous transluminal coronary 
angioplasty (PTCA) (OECD 2013a). 
Australia’s Separation-based AMI 30-day in-hospital mortality rate for adults aged 45 and over 
was lower than the OECD average from 2001 onward. The rate in Australia fell more than 
the OECD average, from around 15% lower in 2001 (9.4 deaths per 100 separations compared 
with 11.2), 20% lower in 2006 (6.7 compared with 8.3), and 25% lower in 2011 (4.8 compared 
with 6.3) (OECD 2013a). The lowest rate among the 32 countries that reported Acute 
myocardial infarction 30-day in-hospital mortality rate in 2011 was 3.0 per 100 separations in 
Denmark; the highest was 27.2 in Mexico. 
Separation-based stroke 30-day in-hospital mortality 
Separation-based haemorrhagic stroke 30-day in-hospital mortality rate was not published in 
HAAG 2013; however, is it reported (for the 23 countries in 2011) on OECD.StatExtracts 
(OECD 2013b). In 2011, for adults aged 45 and over Australia’s rate (22 per 100 separations) 
was similar to the AIHW-calculated average of 21 per 100 admissions (OECD 2013a). 
Australia’s 2010–11 Separation-based ischaemic stroke 30-day in-hospital mortality rate for adults 
aged 45 and over (10.0 per 100 separations) was higher than the 2011 OECD average (7.8) 
(OECD 2013a). A total of 31 countries contributed results to the Separation-based ischaemic 
stroke 30-day in-hospital mortality rate. The lowest rate was in Japan (3.0 per 100 separations); 
the highest was in Mexico (19.6 deaths per 100 admissions). 
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5 Mental health-care indicators 
This chapter presents data for the mental health-care indicators supplied for Australia to the 
2013 HAAG HCQI data collection. It compares these data with the HCQI results for OECD 
countries published in HAAG 2013, and comments on international comparability. 
The mental health-care indicators are all unplanned hospital readmission rates for either 
schizophrenia or bipolar disorder. They entail the need to identify an index separation in 
which the patient is recognised as having the condition.  
The index separation is the first separation per patient in a calendar year with the codes for 
the relevant condition as the principal diagnosis or as one of the first two listed additional 
diagnoses. All these separations count for the denominator of the indicator.  
Any separation with a selected mental health diagnosis within 30 days of discharge from the 
index separation is considered an unplanned readmission and counts for the numerator. A 
single patient may have one, many, or no unplanned readmissions within 30 days of 
discharge from the index separation. 
Codes, numerators and denominators for indicators are detailed in Section B.3 in 
Appendix B. 
Mental health-care indicators submitted to the 2013 HAAG HCQIs collection are: 
• Same hospital readmissions within 30 days for patients discharged with schizophrenia 
• Same hospital readmissions within 30 days among patients discharged with schizophrenia 
• Same hospital readmissions within 30 days for patients discharged with bipolar disorder 
• Same hospital readmissions within 30 days among patients discharged with bipolar disorder. 
The indicators described as ‘…for patients discharged with…’ are the average number of 
times that a patient was readmitted to the same hospital.  
Those described as ‘…among patients discharged with…’ are number of patients who had at 
least one readmission, per 100 separations.  
‘The proportion of patients with “within 30-day readmissions” is … used as an indicator of 
the lack of proper management of mental health conditions outside of hospital’ (OECD 
2013a). 
5.1 Schizophrenia readmissions  
Schizophrenia is a mental disorder that affects how a person thinks, feels and acts. Without 
appropriate treatment, it can result in psychotic episodes.  
Same hospital readmissions within 30 days for patients discharged 
with schizophrenia  
Table 5.1 shows the average number of times that patients with an index separation—where 
the patient was recognised as having schizophrenia—were readmitted to the same hospital 
within 30 days with a mental health diagnosis. This number is stable over the 3 years 
reported, and between males and females, at 0.3 readmissions per patient. 
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Table 5.1: Average number of same hospital readmissions within  
30 days, for patients with schizophrenia, Australia, 2009–10 to 2011–12  
Year Male Female Total 
2009–10 0.3 0.3 0.3 
2010–11 0.3 0.3 0.3 
2011–12 0.3 0.3 0.3 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2009–10 to 2011–12. 
Same hospital readmissions within 30 days among patients 
discharged with schizophrenia  
This indicator is the number per 100 patients with an index separation—where the patient 
was recognised as having schizophrenia—of patients who had at least one readmission. For 
every 100 people who had a schizophrenia separation, around 18 were re-admitted within 30 
days with a mental health diagnosis in 2011–12 (Table 5.2). The rates were similar for males 
and females. 
Table 5.2: Number of same hospital readmissions within 30 days,  
per 100 patients, among patients with schizophrenia, Australia,  
2009–10 to 2011–12  
Year Male Female Total 
2009–10 16.6 16.2 16.4 
2010–11 16.8 17.0 16.9 
2011–12 17.7 18.6 18.1 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2009–10 to 2011–12. 
5.2 Bipolar disorder readmissions 
Bipolar disorder is a type of psychiatric disorder that manifests in alternating episodes of 
mania and depression.  
Same hospital readmissions within 30 days for patients discharged 
with bipolar disorder 
This indicator is the average number of times that patients with an index separation—where 
the patient was recognised as having bipolar disorder—were readmitted to the same hospital 
within 30 days with a mental health diagnosis (Table 5.3). This number was stable over the 3 
years reported, and similar for males and females at 0.2 readmissions per patient. 
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Table 5.3: Average number of same hospital readmissions within  
30 days, for patients with bipolar disorder, Australia, 2009–10 to  
2011–12  
Year Male Female Total 
2009–10 0.2 0.2 0.2 
2010–11 0.2 0.2 0.2 
2011–12 0.2 0.3 0.2 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2009–10 to 2011–12. 
Same hospital readmissions within 30 days among patients 
discharged with bipolar disorder 
Table 5.4 shows the number per 100 patients who had an index separation—where the 
patient was recognised as having bipolar disorder—who had at least 1 readmission. For 
every 100 people who had a bipolar disorder separation, around 15 were readmitted within 
30 days with a mental health diagnosis in 2011–12. This rate was similar for males and 
females. 
Table 5.4: Number of same hospital readmissions within 30 days,  
per 100 patients, among patients with bipolar disorder, Australia,  
2009–10 to 2011–12  
Year Male Female Total 
2009–10 13.0 15.1 14.1 
2010–11 13.0 15.0 14.1 
2011–12 15.9 14.8 15.2 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Sources: NHMD, 2009–10 to 2011–12. 
5.3 How does Australia compare internationally? 
This set of mental health indicators uses ‘within 30–day readmissions’ as a proxy for 
unplanned readmissions because many countries, including Australia, cannot differentiate 
between planned and unplanned mental health readmissions. Only the latter—unplanned 
readmissions—indicate poor quality health-care. The specifications excluded same-day 
admissions, which are likely to account for a considerable amount of planned readmissions.  
Modifications were required to adapt the mental health-care indicators specifications for use 
in Australia (see Appendix B for further details).  
Two indicators submitted by Australia were included in HAAG 2013. These were Same 
hospital readmissions within 30 days among patients discharged with schizophrenia and Same 
hospital readmissions within 30 days among patients discharged with bipolar disorder. The other 2 
indicators submitted were not reported in HAAG 2013 or on OECD.StatExtracts (OECD 
2013b). 
HAAG 2013 reports data from 2006 and 2011 or the nearest year. From Australia’s 
submission, data from 2009–10 and 2011–12 were used. Data were age-sex standardised 
based on the 2010 OECD population structure. 
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Same hospital readmissions within 30 days among patients 
discharged with schizophrenia 
The rate for readmission among those who have had a separation with a schizophrenia 
diagnosis in 2011–12 in Australia was 18 per 100 patients compared with an OECD average 
of 13 (among the 15 countries who supplied this indicator). Rates ranged from 5.5 in Mexico 
to 20 in Israel. Although the OECD average had not changed since 2006, the Australian rate 
rose from 16 in 2009–10 (OECD 2013a). 
Same hospital readmissions within 30 days among patients 
discharged with bipolar disorder 
The rate for readmission among those who have had a separation with a bipolar disorder 
diagnosis in 2011–12 in Australia was 15 per 100 patients, higher than the OECD average of 
11 (for 15 countries). Rates ranged from 4.5 in Portugal to 17 in Israel. Australia’s rate rose 
from 14 in 2009–10; the OECD average was relatively stable (OECD 2013a). 
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6 Cancer care indicators 
This chapter presents data for the cancer care indicators supplied for Australia to the 2013 
HAAG HCQI data collection. It compares these data with the HCQI results for OECD 
countries published in HAAG 2013, and comments on international comparability. 
A relatively small number of cancer care indicators made up part of the 2013 HAAG HCQI 
data collection. Cancer care indicators submitted by Australia (1995–2000 to 2005–2010) were 
for: 
• Breast cancer five-year relative survival 
• Cervical cancer five-year relative survival 
• Colorectal cancer five-year relative survival.  
A person’s chance of surviving cancer depends on many factors, including their lifestyle and 
health conditions, the type of cancer they have, how far it had progressed before being 
diagnosed and what kinds of treatment are available. For most cancer patients, the risk of 
dying from other causes is not negligible. Relative survival allows for the contribution of 
cancer to other causes even when a specific underlying cause is known. It compares the 
survival of people diagnosed with cancer with that experienced by people in the general 
population, matched for age, sex and calendar year (AIHW & AACR 2001). 
Five-year relative survival reflects the probability of being alive for at least 5 years after 
diagnosis. For some cancers, survival for 5 years after diagnosis is an important indicator of 
successful cancer management, through either periods of remission or cure, although for 
others there is still a substantial chance that the cancer may recur even after years of 
successful treatment (AIHW 2012c). 
6.1 Breast cancer five-year relative survival 
Five-year relative survival in Australia from breast cancer in females improved over the 
periods 1995–2000 (83%) to 2005–2010 (88%) (Table 6.1).  
Table 6.1: Five-year relative survival from breast cancer, females, percent, Australia, 1995–2000 to 
2005–2010  
Time period 
1995–
2000 
1996–
2001 
1997–
2002 
1998–
2003 
1999–
2004 
2000–
2005 
2001–
2006 
2002–
2007 
2003–
2008 
2004–
2009 
2005–
2010 
Relative survival, 
per cent  83.2 83.9 84.6 85.2 85.8 86.1 86.5 86.8 87.2 87.5 87.7 
Note: Survival rates were age-standardised to the International Cancer Survival Standard population, 2004. 
Source: AIHW Australian Cancer Database 2007. 
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6.2 Cervical cancer five-year relative survival 
Five-year relative survival from cervical cancer in Australia remained relatively stable over 
the periods 1995–2000 to 2005–2010, at around 68% (Table 6.2). 
Table 6.2: Five-year relative survival from cervical cancer, percent, Australia, 1995–2000 to  
2005–2010  
Time period 
1995–
2000 
1996–
2001 
1997–
2002 
1998–
2003 
1999–
2004 
2000–
2005 
2001–
2006 
2002–
2007 
2003–
2008 
2004–
2009 
2005–
2010 
Relative survival, 
per cent  68.6 68.1 68.3 67.6 67.6 67.2 67.0 67.9 67.4 67.9 67.5 
Note: Survival rates were age-standardised to the International Cancer Survival Standard population, 2004. 
Source: AIHW Australian Cancer Database 2007. 
6.3 Colorectal cancer five-year relative survival 
Over the periods 1995–2000 to 2005–2010, 5-year relative survival for colorectal cancer in 
Australia improved from 58% to 65% in males and from 60% to 68% in females (Table 6.3).  
Table 6.3: Five-year relative survival from colorectal cancer,  
percent, Australia, 1995–2000 to 2005–2010 
Time period Males Females Total 
1995–2000 57.9 59.7 58.6 
1996–2001 58.5 60.4 59.3 
1997–2002 59.7 61.4 60.4 
1998–2003 60.5 62.3 61.3 
1999–2004 61.3 63.2 62.1 
2000–2005 62.0 64.1 62.9 
2001–2006 62.7 65.1 63.7 
2002–2007 63.4 65.6 64.3 
2003–2008 63.9 66.4 65.1 
2004–2009 64.5 67.1 65.7 
2005–2010 65.0 67.7 66.2 
Note: Survival rates were age-standardised to the International Cancer Survival  
Standard population, 2004. 
Source: AIHW Australian Cancer Database 2007. 
6.4 How does Australia compare internationally? 
For cervical cancer and breast cancer, HAAG 2013 published OECD cancer survival data for 
2001–2006 and 2006–2011; they were compared to data available in Australia for the nearest 
period (2001–2006 and 2005–2010). For colorectal cancer, OECD data for 2006–2011 were 
compared to Australian data for 2005–2010. Nineteen member countries reported relative 
survival rates for cervical and breast cancer, while 22 countries provided data for colorectal 
cancer. Australia’s relative survival for each of the 3 cancers was better than the OECD 
average (OECD 2013a). 
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All survival estimates published in HAAG 2013 were age-standardised to the International 
Cancer Survival Standard population, 2004. 
Breast cancer five-year relative survival 
In Australia, 5-year relative survival from breast cancer in females in 2005–2010 (88%) was 
higher than the OECD average (84%), a consistent feature since 2001–2006 (87% and 83% 
respectively). Poland had the lowest 5-year relative survival from breast cancer (74% in  
2003–2008). The United States had the highest relative survival (89%, also reported for  
2003–08) (OECD 2013a). 
Cervical cancer five-year relative survival 
Five-year relative survival from cervical cancer in Australia was about 67% or 68% between 
the periods 2001–2006 and 2005–2010. This was slightly above the average of the OECD 
countries, where 5-year relative survival was about 65% to 66% between 2001–2006 and 
2006–2011. Internationally, relative survival from cervical cancer ranged from 53%  
(2003–2008) for Poland to 77% (2006–2011) for South Korea (OECD 2013a). 
Colorectal cancer five-year relative survival 
Five-year relative survival from colorectal cancer in Australia in 2005–2010 was 66%. For 
males, 5-year relative survival was slightly lower (65%) than for females (68%). Both rates 
were higher than the OECD averages of 61% for males and 63% for women. Survival rates 
ranged from 48% to 73% across OECD member countries, with Poland and South Korea 
reporting the lowest and highest rates respectively (OECD 2013a). 
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7 Patient safety indicators 
This chapter presents data for the patient safety indicators supplied for Australia to the 2013 
HAAG HCQI data collection. It compares these data with the HCQI results for OECD 
countries published in HAAG 2013, and comments on international comparability. 
The patient safety indicators (PSIs) are a set of quality measures that use hospital separation 
data to provide a perspective on patient safety for the purpose of international comparison of 
health systems. PSIs screen for events that patients experience during their hospital stays as a 
result of exposure to the health-care system—either adverse events, which cannot be totally 
avoided, or events that should never occur (OECD 2013a).  
For the 2013 OECD HCQI data collection, Australia submitted results for all ten PSIs in the 
data collection, based on 2011–12 data. The indicators were: 
• Retained surgical item or unretrieved device fragment 
• Accidental puncture or laceration 
• Postoperative haemorrhage or haematoma 
• Postoperative wound dehiscence 
• Postoperative pulmonary embolism or deep vein thrombosis: 
– all surgical discharges 
– hip and knee replacement discharges 
• Postoperative sepsis: 
– all surgical discharges 
– abdominal discharges 
• Obstetric trauma vaginal delivery: 
– with instrument 
– without instrument. 
Where these indicators were submitted to the 2011 OECD HCQI data collection, these data are 
also presented in this chapter. This includes the indicator Catheter-related bloodstream infection, 
an indicator that was not requested for the 2013 collection.  
It should be noted that data from the AIHW’s NHMD are collected primarily for the 
purposes of recording care provided to admitted patients, and that use for purposes such as 
reporting the OECD HCQIs has not been validated for accuracy in Australia. The results 
prepared using data from the NHMD should therefore be treated with caution.  
7.1 Retained surgical item or unretrieved device 
fragment 
In HAAG 2013 this indicator is referred to as Foreign body accidentally left in during a procedure 
(for example, surgical sponges, surgical instruments). Australia’s 2011–12 rate for this 
indicator (8.4 per 100,000 separations) was lower than the 2008–09 rate of 9.4. The crude rate 
for Australia in 2011–12 was higher for males than for females—8.9 and 8.0 respectively and 
more than twice the rate for children aged 0–14 (3.9 for boys and 3.1 for girls) (Table 7.1). 
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Table 7.1: Retained surgical item or unretrieved device fragment rate(a), by sex, adults and children, 
Australia, 2008–09 and 2011–12  
Year 
Male  Female  Total 
Children 0–14 Adults 15+  Children 0–14 Adults 15+  Children 0–14 Adults 15+ 
2008–09 . . 10.5   . . 8.5   . . 9.4 
2011–12 3.9 8.9  3.1 8.0  3.6 8.4 
(a) Crude rate per 100,000 separations, excluding same-day separations. 
Sources: NHMD 2008–09 and 2011–12. 
7.2 Accidental puncture or laceration 
Some complex procedures involve an enhanced risk of accidental cut, puncture, perforation 
or laceration. However, accidents of this nature can also occur in relatively routine 
procedures. Adverse events of this nature may occur because of system problems such as 
inadequate professional training or fatigue (Romano 2007; Millar & Mattke 2004). 
Table 7.2 shows that Australia’s crude rate of Accidental puncture or laceration for adults 15 
and over was just over 300 per 100,000 separations in 2011–12. Accidental puncture or 
laceration was higher for females (330) than for males (280). The rate for children aged 0–14, 
was much lower at 67. 
Table 7.2: Accidental puncture or laceration rate(a), by sex, adults and children, Australia, 2008–09 
and 2011–12 
Year 
Male  Female  Total 
Children 0–14 Adults 15+  Children 0–14 Adults 15+  Children 0–14 Adults 15+ 
2008–09 . . 278.7  . . 335.3  . . 307.1 
2011–12 67.7 281.1  65.5 330.5  66.8 306.0 
(a) Crude rate per 100,000 separations, excluding same-day separations. 
Sources: NHMD 2008–09 and 2011–12. 
7.3 Postoperative haemorrhage or haematoma 
Table 7.3 presents crude rates for this indicator in Australia for 2011–12. The crude rate for 
adults aged 15 and over was almost 1,330 per 100,000 separations, nearly 3 times the rate for 
children (490). The rate for adult males (almost 1,500) was higher than for females (just over 
1,200), but the rates for boys and girls were similar. The indicator was not part of the 
collection in 2011. 
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Table 7.3: Postoperative haemorrhage or haematoma rate(a), by sex, adults and children, Australia, 
2011–12  
Year 
Male  Female  Total 
Children 0–14 Adults 15+  Children 0–14 Adults 15+  Children 0–14 Adults 15+ 
2011–12 490.8 1,452.8  485.2 1,209.4  488.3 1,326.8 
(a) Crude rate per 100,000 separations. 
Source: NHMD 2011–12. 
7.4 Postoperative wound dehiscence 
The 2011–12 rate of Postoperative wound dehiscence (where a wound ruptures along the 
surgical suture) in adults aged 15 and over was more than 110 per 100,000 separations. This 
rate has dropped since 2009–10 (more than 130) (Table 7.4). Rates for males were higher than 
for females (140 and 90 respectively in 2011–12). Although rates for children appear to be 
rising, this is based on very few cases; for example, in 2011–12 there were just 9 cases of 
Postoperative wound dehiscence in more than 25,000 separations for children 0–14. 
Table 7.4: Postoperative wound dehiscence rate(a), by sex, adults and children, Australia, 2009–10 
and 2011–12 
Year  
Male  Female  Total 
Children 0–14 Adults 15+  Children 0–14 Adults 15+  Children 0–14 Adults 15+ 
2009–10 21.6 151.8  58.4 113.5  37.3 131.0 
2010–11 41.6 132.8  84.6 101.9  59.9 116.1 
2011–12 139.4 139.9  53.4 88.9  102.6 112.1 
(a) Crude rate per 100,000 separations, excluding lengths of stay less than 2 days. 
Sources: NHMD 2009–10 to 2011–12. 
7.5 Postoperative pulmonary embolism or deep vein 
thrombosis  
Australia’s rate for this indicator in 2011–12 for all surgical separations was almost 1,300 per 
100,000 separations, a rise of around 25% from about 970 in 2008–09 (Table 7.5).  
In 2011–12, this indicator was reported separately for hip and knee replacement separations, 
as these are high-risk procedures with higher rates expected (OECD 2013a). This expectation 
is met by a rate that is 25% higher than for all surgeries (more than 1,700 per 100,000 
separations, which was similar in men and women).  
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Table 7.5: Postoperative pulmonary embolism or deep vein thrombosis  
rate(a), by sex, Australia, 2008–09 and 2011–12  
Year Male Female Total 
All surgical separations  
2008–09 1,018.7 930.9 974.1 
2011–12 1,271.5 1,264.1 1,267.7 
Hip and knee replacement separations 
2008–09 . . . . . . 
2011–12 1,690.2 1,719.6 1,706.6 
(a) Crude rate per 100,000 separations, excluding lengths of stay less than 2 days. 
Sources: NHMD 2008–09 and 2011–12. 
7.6 Postoperative sepsis 
Postoperative sepsis (infection) is a severe complication that has a high mortality rate. The risk 
of sepsis following abdominal surgery is higher and was added to the OECD HCQI data 
collection in 2013 (OECD 2013a).  
Australia’s 2011–12 rate for postoperative sepsis following surgery was almost 920 per 
100,000 separations, up from almost 790 in 2008–09 (Table 7.6). The rate of postoperative 
sepsis in Australia for males was almost twice the rate for females in all the reported data.  
Table 7.6: Postoperative sepsis rate(a), by sex, Australia, 2008–09 and 2011–12 
Year Male Female Total 
All surgical separations 
2008–09 1043.8 580.2 789.5 
2011–12 1176.8 725.5 919.6 
Abdominal separations 
2008–09 . . . . . . 
2011–12 1660.9 832.5 1124.6 
(a) Crude rate per 100,000 discharges, excluding lengths of stay less than 3 days. 
Sources: NHMD 2008-09 and 2011–12. 
7.7 Obstetric trauma 
The OECD’s PSIs define obstetric trauma as third and fourth degree perineal lacerations that 
arise during delivery. In 2011–12 in Australia, the rate of obstetric trauma for vaginal 
delivery with instrument such as forceps or vacuum, at 7.3 per 100 vaginal deliveries, was 
almost 4 times that of vaginal delivery without an instrument (2.2). There has been little 
change in this rate over time, with the rate for obstetric trauma with instrument 7.4 and 
without instrument 2.0 per 100 vaginal deliveries in 2008–09 (NHMD 2011–12). 
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7.8 Catheter-related bloodstream infection  
This indicator includes not only catheter-related bloodstream infections, but also infections 
following infusions, therapeutic injections, immunisation, and implantation of selected 
cardiac and vascular devices (see Appendix B). 
This indicator was not part of the indicator set for the 2013 OECD HCQI data collection. 
However, Australia’s 2008–09 rate of Catheter-related blood stream infection, calculated for the 
2011 OECD HCQI data collection, was almost 280 per 100,000 separations. Australia’s crude 
rate increased from more than 270 in 2007–08 to 300 in 2009–10. 
7.9 How does Australia compare internationally? 
Australia has supplied data for 2008–09 and 2011–12. Data for 2011–12 were used in HAAG 
2013, as these most closely align with the 2011 reporting period of the report. 
Given the large variations highlighted in rates reported for PSI, in some cases 10 or 20-fold 
variations, it is likely that differences in reporting have a considerable impact. This was 
recognised in HAAG 2013: ‘The extent … to which payments are determined by diagnosis or 
procedure lists may also influence recording’. The report also comments that ‘higher adverse 
event rates may signal more developed patient safety monitoring systems rather than worse 
care’ (OECD 2013a).  
HAAG 2013 also notes that ‘A fundamental challenge in international comparison of patient 
safety indicators centres on the quality of the underlying data. The indicators are typically 
derived from administrative databases, rather than systems specifically designed to monitor 
adverse events, hence differences in how countries record diagnoses and procedures and 
define hospital episodes can affect calculation of rates.’ (OECD2013a). 
There is, largely, a lack of financial disincentives connected to the reporting of adverse events 
in Australia and this may have contributed to the relatively high rates reported for Australia. 
It is also possible that efforts to improve coding quality and to improve the focus on patient 
safety in Australia in recent years could have led to increased reporting of patient safety 
events in Australia compared with some other OECD countries.  
A number of features of Australian patient safety monitoring would support the claim that 
Australia is one of those countries that have a more developed patient safety monitoring 
system. Australia employs specially trained staff to identify and code information from 
patient records. This practice was identified in HAAG 2013 as likely to provide better data 
than systems that rely on report by clinicians that may be more patchy (OECD 2013a). It is 
likely that in Australia additional diagnoses are generally well recorded at the national level 
due to the ability to record up to 99 additional diagnoses in the AIHW NHMD. An 
examination of 2009 data from 14 OECD countries showed a positive relationship between 
the number of additional diagnoses present in hospitalisation records and the crude rate of 
PSIs (note that obstetric trauma PSIs were not included in this study). Specifically, the more 
additional diagnoses, the higher the PSI rate (Drösler et al. 2011). The rates published in 
HAAG 2013 for surgical complications were adjusted by the average number of additional 
diagnoses, but despite this HAAG 2013 remarked that there may still be some 
underestimation for countries that report fewer than 1.5 diagnoses (OECD 2013a). 
Surgical complications and obstetric trauma published in HAAG 2013 included rates that are 
not age-sex standardised. The OECD comments that this rate was not age-sex standardised 
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as it ‘makes a marginal difference to countries’ reported rate or ranking relative to other 
countries’ (OECD 2013a). Neither were data adjusted for other variations among countries in 
casemix that could also affect risk of complications occurring.  
Some of the PSI specifications exclude some separations based on LOS (length of stay)—for 
example the specification for Postoperative PE or DVT and Postoperative wound dehiscence 
exclude separations with a LOS less than 2 days and Postoperative sepsis excludes separations 
less than 3 days. Australia’s average LOS for separations in 2010 (5.8 days) was below the 
OECD average of 8.0 days (OECD 2013a).  
In a country where the average LOS was higher than in Australia, selecting cases from 
hospitalisations with LOS greater than 2 or 3 days would be likely to include a greater 
proportion of their hospitalisations, adding more of the less-complex cases. The proportion 
of more-complex cases in the mix for each country could possibly increase the rates for 
selected PSIs.  
Rates reported in HAAG 2013 are adjusted by the average number of additional diagnoses 
available for all PSIs except obstetric PSIs.  
The indicators Accidental puncture or laceration, Postoperative haemorrhage or haematoma and 
Postoperative wound dehiscence were not reported in HAAG 2013. Postoperative wound dehiscence 
was included in OECD.StatExtracts (OECD 2013b). 
Retained surgical item or unretrieved device fragment 
HAAG 2013 reported a large range of results from the 20 countries that contributed to this 
indicator, from 0.5 in Belgium to 11.6 in Switzerland. The 2011 OECD average for diagnoses 
of Retained surgical item or unretrieved device fragment was 5.0 per 100,000 separations with 
Australia’s reported rate higher at 8.6 (OECD 2013a). 
Postoperative wound dehiscence  
OECD.StatExtracts reported adjusted rates for Postoperative wound dehiscence ranging from 42 
in Switzerland to more than 1,150 per 100,000 hospital discharges in Norway. This was 
compared with Australia’s adjusted rate of just over 100. The AIHW calculates the average 
from the 19 countries that supplied data (which the OECD also adjusted by the average 
number of secondary diagnoses) to be just over 350 per 100,000 hospital discharges.  
Postoperative pulmonary embolism or deep vein thrombosis  
There were large variations in the reported rates of postoperative embolism or deep vein 
thrombosis between OECD countries. As detailed above in this section, it is likely that 
differences in their respective reporting approaches had a considerable impact on the 
variation in the results reported. It is possible that Australia’s approaches to patient safety 
monitoring and recording contributes to the difference between number of reported events 
in Australia and in other OECD countries.  
Australia’s 2011–12 adjusted postoperative embolism or deep vein thrombosis rates for all 
surgeries was just over 1,200. The 2011 OECD average was 600 per 100,000 separations 
respectively. For hip and knee replacements the Australian rate was almost 1,800, while the 
2011 OECD average was over 500. The range of adjusted rates reported for postoperative PE 
or DVT— all surgeries was large: from just over 100 in Belgium to Australia’s rate of more 
than 1,200, with countries spread across that range. There was a similar spread of results 
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reported for postoperative PE or DVT—hip and knee replacement, from about 90 in 
Denmark to Australia’s rate of almost 1,800 (OECD 2013a).  
Postoperative sepsis 
Adjusted rates of sepsis following abdominal surgeries in Australia were lower than the 
OECD average (more than 1,500 and 1,600 per 100,000 separations respectively), but the rate 
of sepsis following all surgeries was higher in Australia at almost 1,100 compared with more 
than 780 on average across the 20 OECD countries contributing to this indicator. The range of 
rates reported in HAAG 2013 for both abdominal and all surgeries postoperative sepsis was 
considerable, from just under 100 per 100,000 in Israel to almost 1,700 in Ireland for all 
surgeries and from around 450 in Israel to more than 3,000 in Spain for abdominal surgeries 
(OECD 2013a).  
Obstetric trauma 
HAAG 2013 notes that for obstetric trauma ‘differences in data reporting across countries 
may influence the calculated rates of obstetric PSIs. These relate primarily to differences in 
coding practices and data sources’. There is some evidence that countries that rely on data 
from registries produce higher quality data and report a greater number of obstetric trauma 
events compared to administrative datasets (OECD 2013a). Australia’s obstetric trauma data 
were prepared using NHMD, which would be classified as an administrative dataset. 
The 2011 OECD average (over 21 countries) for obstetric trauma for Vaginal delivery with 
instrument was 6.0 per 100 patients. Australia’s crude rate was 7.3, with the range from 0.5 in 
Poland to 17.3 in Denmark (OECD 2013a). 
For Vaginal deliveries without instrument, Australia’s crude rate (2.2 per 100 patients) was also 
higher than the OECD average (1.6), with the range from 0.1 in Poland to 3.7 in Switzerland 
(OECD 2013a). 
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8 Patient experience indicators 
This chapter presents data for the patient experience indicators supplied for Australia to the 
2013 HAAG HCQI data collection. It compares these data with the HCQI results for OECD 
countries published in HAAG 2013, and comments on international comparability. 
Five indicators of patient experience were supplied from the 2011–12 ABS Patient Experience 
Survey for the 2012–13 HAAG data collection. The remaining 9 indicators used data items 
that are not currently collected. The 5 indicators supplied were: 
• Consultation skipped due to difficulties in travelling 
• Consultation skipped due to costs 
• Medical tests, treatment or follow-up skipped due to costs 
• Prescribed medicines skipped due to costs 
• Doctor spending enough time with patients during the consultation. 
For the ‘consultation skipped’ indicators, the ABS survey asked people various questions 
about their experience with GPs, medical specialists, dental professionals or hospitals, 
whereas the OECD HCQI specified ‘a health professional’ (for example, a doctor, nurse or 
allied health professional). 
Confidence intervals (CIs) have been included for these data as explained in Chapter 2: 
Methods. 
8.1 Consultation skipped due to difficulties in 
travelling 
The ABS Patient Experience Survey found that about 1 per 100 people aged 15 and over 
reported skipping a consultation due to difficulties with travelling in 2011–12 in Australia. 
This rate was lower for males (0.7 per 100 people) than females (1.3) (Table 8.1). 
Table 8.1: Consultations skipped due to difficulties in travelling for people aged 15 and over, 
number per 100 people, Australia, 2011–12  
Year 
Male  Female  Total 
Rate 
95% CI 
Lower limit 
95% CI 
Upper limit  Rate 
95% CI 
Lower limit 
95% CI 
Upper limit  Rate 
95% CI 
Lower limit 
95% CI 
Upper limit 
2011–12 0.73 0.51 0.95  1.34 1.08 1.60  1.04 0.87 1.21 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Source: ABS Patient Experience Survey 2011–12. 
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8.2 Consultation skipped due to costs 
In 2011–12 in Australia, almost 19 per 100 people aged 15 and over reported skipping a 
consultation due to costs. This rate was higher among females (22 per 100 people) than  
males (16). 
Table 8.2: Consultations skipped due to costs for people aged 15 and over, number per 100 people, 
Australia, 2011–12  
Year 
Male  Female  Total 
Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit 
2011–12 15.99 15.14 16.83  21.69 20.90 22.49  18.86 18.27 19.44 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Source: ABS Patient Experience Survey 2011–12. 
8.3 Medical tests, treatment or follow-up skipped 
due to costs 
This indicator was supplied using the ABS Patient Experience Survey question that asked 
people whether they delayed or did not get referred pathology or imaging tests because of 
cost. In 2011–12 in Australia, 4.9 per 100 people aged 15 and over delayed or skipped a 
pathology or imaging test due to cost. 
Table 8.3: Delayed or skipped pathology or imaging test due to cost for people aged 15 and over, 
number per 100 people, Australia, 2011–12 
Year 
Male  Female  Total 
Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit 
2011–12 4.29 3.61 4.97  5.43 4.92 5.94  4.87 4.44 5.30 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Source: ABS Patient Experience Survey 2011–12. 
8.4 Prescribed medicines skipped due to costs 
For this indicator, the ABS Patient Experience Survey asked whether the interviewee delayed 
or did not get prescription due to cost. In 2011–12 in Australia, 9.2 per 100 people aged 15 
and over reported having delayed or skipped medicines. More females delayed or skipped 
getting a prescription than males (10.9 compared with 7.6 per 100 people). 
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Table 8.4: Delayed or skipped prescribed medicines due to cost for people aged 15 and over, 
number per 100 people, Australia, 2011–12 
Year 
Male  Female  Total 
Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit 
2011–12 7.57 6.80 8.34  10.89 10.17 11.61  9.23 8.70 9.76 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Source: ABS Patient Experience Survey 2011–12. 
8.5 Doctor spending enough time with patients 
during the consultation 
This indicator was supplied using a question for which respondents who saw a GP for their 
own health were asked to ‘Think about all the GPs you have seen in the last 12 months. How 
often did they spend enough time with you?’. Possible responses were: always, often, 
sometimes or rarely. Responses of always and often were the responses considered to be 
equivalent to yes for the OECD HCQIs.  
In 2011–12 in Australia, 87 per 100 people aged 15 and over said that of all the GPs seen in 
the past 12 months, the doctor had always or often spent enough time with them. These rates 
were similar for males and females (86 and 87 respectively). 
Table 8.5: Doctor spending enough time with patients during the consultation for people aged 15 
and over, number per 100 people, Australia, 2011–12 
Year 
Male  Female  Total 
Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit  Rate  
95% CI 
Lower limit 
95% CI 
Upper limit 
2011–12 87.20 86.31 88.09  85.87 85.14 86.60  86.53 85.96 87.11 
Note: Rates are age-sex standardised to the 2010 OECD population. 
Source: ABS Patient Experience Survey 2011–12. 
8.6 How does Australia compare 
Three of the 4 tables presented in HAAG 2013 contain data for Australia that were sourced 
from the Commonwealth Fund’s International health policy survey 2010.  
The only indicator submitted by Australia published in HAAG 2013 was Doctor spending 
enough time with patients during a consultation. The OECD recommends monitoring patient 
experience with any doctor (OECD 2013a), as Australia has done, but the majority of other 
countries to which Australia is compared measure experience with a patient’s regular doctor. 
The ABS Patient Experience Survey does not distinguish between the concepts of ‘regular 
doctor’ and ‘doctor’. 
In 2011–12 in Australia, 87 per 100 people aged 15 and over said that of all the GPs seen in 
the past 12 months, the doctor had always or often spent enough time with them. This is the 
same as the OECD average across the 14 countries that contributed to the indicator. Rates 
ranged from 74 in Sweden to 97 per 100 interviewees in the Czech Republic (OECD 2013a). 
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Appendix A: Data quality statement 
summaries 
This appendix includes data quality summaries relevant to interpretation of the: 
• National Hospital Morbidity Database (NHMD) 
• Australian Cancer Database (ACD). 
Complete data quality statements for these databases are available online at 
<www.aihw.gov.au>. 
A data quality statement for the Patient Experience Survey is available online at 
<www.abs.gov.au>. 
National Hospital Morbidity Database  
The NHMD is a compilation of episode-level records from admitted patient morbidity data 
collection systems in Australian hospitals.  
The data supplied are based on the national minimum data set (NMDS) for admitted patient 
care. They include demographic, administrative and length of stay data, as well as data on 
the diagnoses of the patients, the procedures they underwent in hospital and external causes 
of injury and poisoning. 
The purpose of the NMDS for admitted patient care is to collect information about care 
provided to admitted patients in Australian hospitals. The scope of the NMDS is episodes of 
care for admitted patients in all public and private acute and psychiatric hospitals, 
free-standing day hospital facilities and alcohol and drug treatment centres in Australia. 
Hospitals operated by the Australian Defence Force, corrections authorities and in 
Australia’s off-shore territories are not in scope, but some are included.  
The latest reference period for this data set is 2011–12. The data set includes records for 
admitted-patient separations between 1 July 1993 and 30 June 2012.  
Summary of key issues 
• The NHMD is a comprehensive data set that has records for all separations of admitted 
patients essentially from all public and private hospitals in Australia.  
• A record is included for each separation, not for each patient, so patients who separated 
more than once in the year have more than one record in the NHMD. 
• For 2011–12, almost all public hospitals provided data for the NHMD.  
• There is apparent variation between states and territories in the use of statistical 
discharges and associated assignment of care types.  
• There was some variation between states and territories in the reporting of separations 
for Newborns (without qualified days). 
• Variations in admission practices and policies lead to variation among providers in the 
number of admissions for some conditions. 
• Caution should be used in comparing diagnosis, procedure and external cause data over 
time, as the classifications and coding standards for those data can change over time. In 
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particular, between 2009–10 and 2010–11, there were significant changes in the coding of 
diagnoses for diabetes and obstetrics and for reporting imaging procedures. 
Australian Cancer Database  
To avoid excessive repetition in what follows, the word ‘cancer’ is used to mean ‘cancer, 
excluding basal cell carcinomas of the skin and squamous cell carcinomas of the skin’. In 
most states and territories these two very common skin cancers are not notifiable diseases 
and as such are not in the scope of the ACD. 
All states and territories have legislation that makes cancer a notifiable disease. All hospitals, 
pathology laboratories, radiotherapy centres and registries of births, deaths and marriages 
must report cancer cases and deaths to the state or territory population-based cancer registry. 
Each registry supplies incidence data annually to the AIHW under an agreement between 
the registries and the AIHW. These data are compiled into the ACD, the only repository of 
national cancer incidence data. 
Summary of key issues 
• All states and territories maintain a population-based cancer registry to which all cancer 
cases and deaths must be reported.  
• The AIHW compiles the ACD using information from state and territory registers.  
• Some duplication may occur where the same person and cancer have been registered in 
two or more jurisdictions. The AIHW provisionally resolves these instances and notifies 
the relevant states and territories of possible duplicates. Full resolution has usually 
occurred by the following year’s version of the ACD.  
• The level of duplication is small, about 0.17% of all records.  
• Cancer registry databases change every day, adding new records and improving the 
quality of existing records as new information becomes available. Information on ACD 
records may therefore change from year to year. 
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Appendix B: OECD HCQI specifications 
This appendix summarises the technical specifications for the 2012–13 OECD HCQI data 
collection provided to the AIHW by the OECD: 
• OECD Health Care Quality Indicators 2012–13 Data Collection: Guidelines for filling in the 
data collection questionnaires 
• OECD Health Care Quality Indicators 2012–13 Data Collection: Technical manual for patient 
safety indicators. 
These specifications include numerators and denominators of each indicator, with inclusions 
and exclusions specified where necessary. ICD-9-CM and ICD-10 code lists (referred to here 
as ICD-10-WHO to clearly distinguish from ICD-10-AM) were supplied as part of the 
technical specifications for most indictors. Where the AIHW’s method for preparing an 
indicator differed from the specification, this is noted in the relevant section.  
Code lists for excluded cases, named at each specification, are given in full here only where a 
mapping was required. Other code list for excluded cases—for example specifying newborns 
or infection—can be obtained by contacting the AIHW.  
B.1 Primary care indicators 
ICD-10-WHO codes supplied by the OECD for primary care indicators were assessed by the 
AIHW and found to be equivalent with ICD-10-AM codes. However, some codes supplied as 
ICD-9-CM were mapped by the AIHW to appropriate Australian Classification of Health 
Interventions (ACHI) codes. 
Asthma hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (age 15+) with a principal 
diagnosis code of asthma (Table B.1) in a specified year. 
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• with any diagnosis code of cystic fibrosis and anomalies of the respiratory system 
• same-day separations.  
Table B.1: ICD-10 (WHO and AM) codes for asthma  
Code  Description 
J45.0  Predominantly allergic asthma 
J45.1  Nonallergic asthma 
J45.8  Mixed asthma 
J45.9  Asthma, unspecified 
J46  Status asthmaticus 
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Chronic obstructive pulmonary disease hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (aged 15 and over) with a 
principal diagnosis code for COPD (Table B.2) in a specified year.  
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• same-day separations.  
Table B.2: ICD-10 (WHO and AM) COPD codes  
Code Description  
J40 Bronchitis(a) 
J41.0 Simple chronic bronchitis  
J41.1 Mucopurulent chronic bronchitis  
J41.8 Mixed simple and mucopurulent chronic bronchitis  
J42 Unspecified chronic bronchitis  
J43.0 Macleod syndrome  
J43.1 Panlobular emphysema  
J43.2 Centrilobular emphysema  
J43.8 Other emphysema  
J43.9 Emphysema, unspecified  
J44.0 COPD with acute lower respiratory infection  
J44.1 COPD with acute exacerbation, unspecified  
J44.8 Other specified chronic obstructive pulmonary disease  
J44.9 Chronic obstructive pulmonary disease, unspecified  
J47 Bronchiectasis  
(a) Qualifies only if accompanied by additional diagnosis of one of the following codes:  
J41 Simple and mucopurulent chronic bronchitis, J43 Emphysema,  
J44 Other chronic obstructive pulmonary disease or J47 Bronchiectasis. 
Congestive heart failure hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (aged 15 and over) with 
principal diagnosis code for CHF (Table B.3) in a specified year.  
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• with cardiac procedure codes in any field (mapping at Table B2) 
• same-day separations.  
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Table B.3: ICD-10 (WHO and AM) CHF codes  
Code Description  
I11.0 Hypertensive heart disease with (congestive) heart failure  
I13.0 Hypertensive heart and renal disease with (congestive) heart failure  
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure  
I50.0 Congestive heart failure  
I50.1 Left ventricular failure  
I50.9  Heart failure, unspecified 
Hypertension hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (aged 15 and over) with 
principal diagnosis code for hypertension (Table B.4) in a specified year.  
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• with cardiac procedure codes in any field (mapping at Table B.10) 
• same-day separations.  
Table B.4: ICD-10 (WHO and AM) hypertension codes  
Code Description  
I10 Essential (primary) hypertension  
I11.9 Hypertensive heart disease without (congestive) heart failure  
I12.9 Hypertensive renal disease without renal failure  
I13.9 Hypertensive heart and renal disease, unspecified 
Uncontrolled diabetes without complications hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (aged 15 and over) with 
principal diagnosis code for uncontrolled diabetes, without mention of a short-term or  
long-term complication (Table B.5) in a specified year.  
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• same-day separations.  
  
  OECD health-care quality indicators for Australia 2011–12 45 
Table B.5: ICD-10 (WHO and AM) uncontrolled diabetes codes  
Code Description 
E10.9  Insulin-dependent diabetes mellitus without complications 
E11.9 Non-insulin-dependent diabetes mellitus without complications  
E13.9  Other specified diabetes mellitus without complications 
E14.9 Unspecified diabetes mellitus without complications 
Diabetes short-term complications hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (aged 15 and over) with a 
principal diagnosis code for diabetes short-term complications (Table B.6) in a specified year.  
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• same-day separations.  
Table B.6: ICD-10 (WHO and AM) diabetes short-term complications 
codes  
Code Description  
E10.0 Insulin-dependent diabetes mellitus with coma  
E10.1 Insulin-dependent diabetes mellitus with ketoacidosis  
E11.0 Non-insulin-dependent diabetes mellitus with coma  
E11.1 Non-insulin-dependent diabetes mellitus with ketoacidosis  
E13.0 Other specified diabetes mellitus with coma  
E13.1 Other specified diabetes mellitus with ketoacidosis  
E14.0 Unspecified diabetes mellitus with coma  
E14.1  Unspecified diabetes mellitus with ketoacidosis 
Diabetes long-term complications hospital separation 
Numerator: All non-maternal/non-neonatal hospital separations (aged 15 and over) with 
principal diagnosis code for diabetes long-term complications (Table B.7) in a specified year. 
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
• principal diagnosis of newborn and other neonates  
• same-day separations.  
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Table B.7: ICD-10 (WHO and AM) diabetes long-term complications codes 
Code Description 
E10.2  Insulin-dependent diabetes mellitus with renal complications 
E10.3  Insulin-dependent diabetes mellitus with ophthalmic complications 
E10.4  Insulin-dependent diabetes mellitus with neurological complications 
E10.5  Insulin-dependent diabetes mellitus with peripheral circulatory complications 
E10.6  Insulin-dependent diabetes mellitus with other specified complications 
E10.7  Insulin-dependent diabetes mellitus with multiple complications 
E10.8  Insulin-dependent diabetes mellitus with unspecified complications 
E11.2  Non-insulin-dependent diabetes mellitus with renal complications 
E11.3  Non-insulin-dependent diabetes mellitus with ophthalmic complications 
E11.4  Non-insulin-dependent diabetes mellitus with neurological complications 
E11.5  Non-insulin-dependent diabetes mellitus with peripheral circulatory complications 
E11.6  Non-insulin-dependent diabetes mellitus with other specified complications 
E11.7  Non-insulin-dependent diabetes mellitus with multiple complications 
E11.8  Non-insulin-dependent diabetes mellitus with unspecified complications 
E13.2  Other specified diabetes mellitus with renal complications 
E13.3  Other specified diabetes mellitus with ophthalmic complications 
E13.4  Other specified diabetes mellitus with neurological complications 
E13.5  Other specified diabetes mellitus with peripheral circulatory complications 
E13.6  Other specified diabetes mellitus with other specified complications 
E13.7  Other specified diabetes mellitus with multiple complications 
E13.8  Other specified diabetes mellitus with unspecified complications 
E14.2  Unspecified diabetes mellitus with renal complications 
E14.3  Unspecified diabetes mellitus with ophthalmic complications 
E14.4  Unspecified diabetes mellitus with neurological complications 
E14.5  Unspecified diabetes mellitus with peripheral circulatory complications 
E14.6  Unspecified diabetes mellitus with other specified complications 
E14.7  Unspecified diabetes mellitus with multiple complications 
E14.8  Unspecified diabetes mellitus with unspecified complications 
Diabetes lower extremity amputation  
Numerator: All non-maternal/non-neonatal separations (aged 15 and over) with procedure 
code for lower extremity amputation excluding toe (Table B.8) in any field and diagnosis 
code of diabetes (Table B.9) in any field in a specified year.  
Procedure codes for lower-extremity amputation excluding toe were supplied by OECD in 
ICD-9-CM only; therefore, the AIHW prepared a mapping to ACHI codes. 
Denominator: 100,000 population (aged 15 and over). 
Exclude cases:  
• transferring from another institution  
• principal diagnosis of pregnancy, childbirth and puerperium  
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• principal diagnosis of newborn and other neonates  
• with traumatic amputation diagnosis code in any field  
• same-day separations. 
Table B.8: Procedure codes for lower-extremity amputation excluding toe map 
ICD-9-CM  ACHI code 
8410 lower limb amputat nos  44370-00 Amputation at hip 
8412 amputation through foot  44373-00 Hindquarter amputation 
8413 disarticulation of ankle  4436700 Amputation above knee 
8414 amputat through malleoli  44367-02 Amputation below knee 
8415 below knee amputat nec  44358-00 Amputation of toe including metatarsal bone 
8416 disarticulation of knee  44361-00 Disarticulation through ankle 
8417 above knee amputation  44364-00 Midtarsal amputation 
8418 disarticulation of hip  44364-01 Transmetatarsal amputation 
8419 hindquarter amputation  44361-01 Amputation of ankle through malleoli of tibia and fibula 
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Table B.9: ICD-10 (WHO and AM) diabetes diagnosis codes  
Code Description 
E10.0  Insulin-dependent diabetes mellitus with coma 
E10.1  Insulin-dependent diabetes mellitus with ketoacidosis 
E10.2  Insulin-dependent diabetes mellitus with renal complications 
E10.3  Insulin-dependent diabetes mellitus with ophthalmic complications 
E10.4  Insulin-dependent diabetes mellitus with neurological complications 
E10.5  Insulin-dependent dm with peripheral circulatory complications 
E10.6  Insulin-dependent dm with other specified complications 
E10.7  Insulin-dependent diabetes mellitus with multiple complications 
E10.8  Insulin-dependent diabetes mellitus with unspecified complications 
E10.9  Insulin-dependent diabetes mellitus without complications 
E11.0  Non-insulin-dependent diabetes mellitus with coma 
E11.1  Non-insulin-dependent diabetes mellitus with ketoacidosis 
E11.2  Non-insulin-dependent diabetes mellitus with renal complications 
E11.3  Non-insulin-dependent dmwith ophthalmic complications 
E11.4  Non-insulin-dependent dm with neurological complications 
E11.5  Non-insulin-dependent dm with peripheral circulatory complications 
E11.6  Non-insulin-dependent dm with other specified complications 
E11.7  Non-insulin-dependent diabetes mellitus with multiple complications 
E11.8  Non-insulin-dependent dm with unspecified complications 
E11.9  Non-insulin-dependent diabetes mellitus without complications 
E13.0  Other specified diabetes mellitus with coma 
E13.1  Other specified diabetes mellitus with ketoacidosis 
E13.2  Other specified diabetes mellitus with renal complications 
E13.3  Other specified diabetes mellitus with ophthalmic complications 
E13.4  Other specified diabetes mellitus with neurological complications 
E13.5  Other specified dm with peripheral circulatory complications 
E13.6  Other specified diabetes mellitus with other specified complications 
E13.7  Other specified diabetes mellitus with multiple complications 
E13.8  Other specified diabetes mellitus with unspecified complications 
E13.9  Other specified diabetes mellitus without complications 
E14.0  Unspecified diabetes mellitus with coma 
E14.1  Unspecified diabetes mellitus with ketoacidosis 
E14.2  Unspecified diabetes mellitus with renal complications 
E14.3  Unspecified diabetes mellitus with ophthalmic complications 
E14.4  Unspecified diabetes mellitus with neurological complications 
E14.5  Unspecified dm with peripheral circulatory complications 
E14.6  Unspecified diabetes mellitus with other specified complications 
E14.7  Unspecified diabetes mellitus with multiple complications 
E14.8  Unspecified diabetes mellitus with unspecified complications 
E14.9  Unspecified diabetes mellitus without complications 
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Cardiac procedure codes 
Cardiac procedure codes (ICD-9-CM codes at Table B.10a and equivalent codes in ACHI at 
Table B.10b) were excluded from the indicators CHF hospital separation and Hypertension 
hospital separation. The AIHW found that mapping was not straightforward in this instance 
and so developed the ACHI code list for use in this indicator based on the ICD-9-CM codes 
supplied by the OECD. 
Table B.10a: ICD-9-CM cardiac procedure codes  
ICD-9-CM ICD-9-CM 
0050 Impl crt pacemaker sys oct02-  3553 Prost repair ventric def 
0051 Impl crt defibrillat oct02-  3554 Pros rep endocar cushion  
0052 Imp/rep lead lf ven sys oct02-  3555 Pros rep ventrc def-clos oct06-  
0053 Imp/rep crt pacemkr gen oct02-  3560 Graft repair hrt sept nos  
0054 Imp/rep crt defib genat oct02-  3561 Graft repair atrial def  
0056 Ins/rep impl sensor lead oct06-  3562 Graft repair ventric def  
0057 Imp/rep subcue card dev oct06-  3563 Graft rep endocar cushion  
0066 Ptca oct06-  3570 Heart septa repair nos  
3500 Closed valvotomy nos  3571 Atria septa def rep nec  
3501 Closed aortic valvotomy  3572 Ventr septa def rep nec 
3502 Closed mitral valvotomy  3573 Endocar cushion rep nec  
3503 Closed pulmon valvotomy  3581 Tot repair tetral fallot  
3504 Closed tricusp valvotomy  3582 Total repair of tapvc  
3510 Open valvuloplasty nos  3583 Tot rep truncus arterios  
3511 Opn aortic valvuloplasty  3584 Tot cor transpos grt ves  
3512 Opn mitral valvuloplasty  3591 Interat ven retrn transp  
3513 Opn pulmon valvuloplasty  3592 Conduit rt vent-pul art  
3514 Opn tricus valvuloplasty  3593 Conduit left ventr-aorta  
3520 Replace heart valve nos  3594 Conduit artium-pulm art  
3521 Replace aort valv-tissue  3595 Heart repair revision  
3522 Replace aortic valve nec  3596 Perc heart valvuloplasty  
3523 Replace mitr valv-tissue  3598 Other heart septa ops  
3524 Replace mitral valve nec  3599 Other heart valve ops  
3525 Replace pulm valv-tissue  3601 Ptca–1 Vessel w/o agent  
3526 Replace pulmon valve nec  3602 Ptca–1 vessel with agnt  
3527 Replace tric valv-tissue  3603 Open coronry angioplasty  
3528 Replace tricusp valv nec  3604 Intrcoronry thromb infus  
3531 Papillary muscle ops  3605 Ptca-multiple vessel  
3532 Chordae tendineae ops  3606 Insert of cor art stent oct95-  
3533 Annuloplasty 3607 Ins drug-elut coronry st oct02-  
3534 Infundibulectomy  3609 Rem of cor art obstr nec  
3535 Trabecul carneae cord op  3610 Aortocoronary bypass nos  
(continued) 
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Table B1.10a (continued): ICD-9-CM cardiac procedure codes  
ICD-9-CM ICD-9-CM 
3539 Tiss adj to valv ops nec  3611 Aortocor bypas–1 cor art  
3541 Enlarge existing sep def  3612 Aortocor bypas–2 cor art  
3542 Create septal defect  3613 Aortocor bypas–3 cor art  
3550 Prosth rep hrt septa nos  3614 Aortcor bypas–4+ cor art  
3551 Pros rep atrial def-opn  3615 1 Int mam-cor art bypass  
3552 Pros repair atria def-cl  3616 2 Int mam-cor art bypass 
3617 Abd-coron art bypass oct96- 3772 Int insert lead atri-vent  
3619 Hrt revas byps anas nec  3773 Int inser lead in atrium  
3633 Oth heart revascular  3774 Int or repl lead epicar  
3631 Open chest trans revasc  3775 Revision of lead  
3632 Oth transmyo revascular  3776 Repl tv atri-vent lead  
3633 Endo transmyo revascular oct06-  3777 Removal of lead w/o repl  
3634 Perc transmyo revascular oct06-  3778 Inser team pacemaker sys  
3639 Oth heart revasular  3779 Revis or relocate pocket  
3691 Coron vess aneurysm rep  3780 Int or repl perm pacemkr  
3699 Heart vessle op nec  3781 Int insert 1-cham, non  
3731 Pericardiectomy  3782 Int insert 1-cham, rate  
3732 Heart aneurysm excision  3783 Int insert dual-cham dev  
3733 Exc/dest hrt lesion open  3785 Repl pacem w 1-cham, non  
3734 Exc/dest hrt les other  3786 Repl pacem 1-cham, rate  
3735 Partial ventriculectomy  3787 Repl pacem w dual-cham  
3741 Implant prosth card support dev oct06  3789 Revise or remove pacemak  
375 Heart transplantation (not valid after oct 03)  3794 Implt/repl carddefib tot  
3751 Heart tranplantation oct03-  3795 Implt cardiodefib leads  
3752 Implant tot rep hrt sys oct03-  3796 Implt cardiodefib genatr  
3753 Repl/rep thorac unit hrt oct03-  3797 Repl cardiodefib leads  
3754 Repl/rep oth tot hrt sys oct03-  3798 Repl cardiodefib genratr  
3770 Int insert pacemak lead  3826 Insrt prsr snsn w:o lead 
3771 Int insert lead in vent  
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Table B.10b: ACHI cardiac procedure codes  
ACHI (by block)  ACHI (by block)  
600 Incision procedures on atrium  636 Incision procedures on pulmonary valve 
601 Destruction procedures on atrium 637 Repair or replacement of pulmonary valve 
602 Excision procedures on atrium 638 Other procedures on pulmonary valve 
603 Repair procedures on atrium 639 Incision procedures on myocardium 
604 Reconstruction procedures on atrium 640 Excision procedures on myocardium 
606 Other procedures on atrium 641 Repair procedures on myocardium 
609 Destruction procedures on ventricle 644 Other incision procedures on pericardium 
610 Ventricular myectomy 645 Biopsy of pericardium 
611 Excision of ventricular aneurysm 646 Other excision procedures on pericardium 
612 Other excision procedures on ventricle 647 
Insertion of temporary transvenous electrode for cardiac 
pacemaker or defib 
613 Baffle or conduit procedures 648 
Insertion of permanent transvenous electrode for cardiac 
pacemaker or defib 
614 Other repair procedures on ventricle 649 
Insertion of other electrode or patch for cardiac pacemaker or 
defibrillator 
615 Other procedures on ventricle 650 Insertion of cardiac pacemaker generator 
616 Excision procedures on septum 653 Insertion of cardiac defibrillator generator 
617 Closure of atrial septal defect 654 
Adjustment, replacement or removal of electrode for cardiac 
pacemaker or defib 
618 Closure of ventricular septal defect 655 
Adjustment, replacement or removal of cardiac pacemaker 
generator 
619 Other repair procedures on septum 656 
Adjustment, replacement or removal of cardiac defibrillator 
generator 
620 Other procedures on septum 660 Transplantation of heart or lung 
621 Incision procedures on aortic valve 661 Other repair procedures on other sites of heart 
622 Repair of aortic valve 662 Reconstruction procedures on other sites of heart 
623 Replacement of aortic valve 666 Other procedures on other sites of heart 
624 Other procedures on aortic valve 669 Excision procedures on coronary arteries 
625 Incision procedures on mitral valve 670 Transluminal coronary angioplasty 
626 Repair of mitral valve 671 Transluminal coronary angioplasty with stenting 
627 Mitral valve annuloplasty 672 Coronary artery bypass - saphenous vein graft 
628 Replacement of mitral valve 673 Coronary artery bypass - other vein graft 
629 Reconstruction procedures on mitral valve 674 
Coronary artery bypass - left internal mammary artery [LIMA] 
graft 
630 Other procedures on mitral valve 675 
Coronary artery bypass - right internal mammary artery [RIMA] 
graft 
631 Incision procedures on tricuspid valve 676 Coronary artery bypass - radial artery graft 
632 Repair of tricuspid valve 677 Coronary artery bypass - epigastric artery graft 
633 Tricuspid valve annuloplasty 678 Coronary artery bypass - other artery graft 
634 Replacement of tricuspid valve 679 Coronary artery bypass - other material graft 
635 Other procedures on tricuspid valve 681 Other procedures on coronary arteries 
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B.2 Acute care indicators 
ICD-10-WHO codes supplied by the OECD for acute care indicators were assessed by the 
AIHW and found to be equivalent with ICD-10-AM codes.  
Separation-based AMI 30-day in-hospital mortality  
Numerator: Number of deaths (aged 15 and over) in the same hospital that occurred within 
30 days of hospital admission with principal diagnosis of acute myocardial infarction (Table 
B.11) in a specified year.  
Denominator: Number of hospital separations (aged 15 and over) with principal diagnosis 
of acute myocardial infarction in the specified year. 
Table B.11: ICD-10 (WHO and AM) AMI codes  
Code Description 
I21 Acute myocardial infarction  
I22  Subsequent myocardial infarction 
Separation-based haemorrhagic stroke 30-day in-hospital mortality  
Numerator: Number of deaths (aged 15 and over) in the same hospital that occurred within 
30 days of hospital admission with principal diagnosis of haemorrhagic stroke (Table B.12) in 
a specified year.  
Denominator: Number of hospital separations (aged 15 and over) with a principal diagnosis 
of haemorrhagic stroke in the specified year. 
Table B.12: ICD-10 (WHO and AM) haemorrhagic  
stroke codes  
Code Description 
I60 Subarachnoid hemorrhage 
I61 Intracerebral hemorrhage 
I62 Other nontraumatic intracranial hemorrhage 
Separation-based ischaemic stroke 30-day in-hospital mortality  
Numerator: Number of deaths (aged 15 and over) in the same hospital that occurred within 
30 days of hospital admission with principal diagnosis of ischaemic stroke (Table B.13) in a 
specified year.  
Denominator: Number of hospital separations (aged 15 and over) with a principal diagnosis 
of ischaemic stroke in the specified year. 
Table B.13: ICD-10 (WHO and AM) ischaemic stroke codes  
Code  Description 
I63 Cerebral infarction 
I64 Stroke, not classified as haemorrhage or infarction 
  OECD health-care quality indicators for Australia 2011–12 53 
B.3 Mental health-care indicators 
ICD-10-WHO codes supplied by the OECD for mental health-care indicators were assessed 
by the AIHW and found to be equivalent with ICD-10-AM codes. 
Readmissions were identified by the presence of a mental health diagnosis code at any 
diagnosis, not restricted to first 3 diagnoses as in the OECD indicator definition. 
For the Australian data, readmissions were counted if they occurred within 30 days of 
separation from the index separation (the first separation of the reference year for that 
patient, for the condition of interest—that is, schizophrenia or bipolar disorder) as no cut–off 
dates to the denominator were specified in the OECD specification. 
Table B.14 lists the selected mental health conditions referred to in the numerator of these 
mental health indicators. 
Table B.14: ICD-10 (WHO and AM) selected mental health-related diagnosis codes  
Code  Mental and behavioural disorders 
F10– F19  Mental and behavioural disorders due to psychoactive substance use  
F20–F29  Schizophrenia, schizotypical and delusional disorders  
F30–F39  Mood [affective] disorders  
F40–F48  Neurotic, stress related and somatoform disorders  
F50–F59  Behavioural syndromes associated with physiological disturbances and physical factors  
F60–F69  Disorders of adult personality and behaviour  
F90–F98  Behavioural and emotional disorders with onset usually occurring in childhood and adolescence  
F99 Unspecified mental disorder 
Same hospital readmissions within 30 days for/among patients 
discharged with schizophrenia (readmission rate and number of 
readmissions) 
Numerator: Total number of unplanned readmissions in a calendar year to the same hospital 
for patients (aged 15 and over) separated from hospital at least once in the referred year with 
a principal diagnosis of one of the selected mental health conditions (Table B.14).  
Denominator: Total number of patients (aged 15 and over) separated at least once from 
hospital in the referred year with a principal or first two listed additional diagnosis of 
schizophrenia (Table B.15).  
Exclusions: 
• same-day separations are excluded from both the numerator and the denominator. 
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Table B.15: ICD-10 (WHO and AM) schizophrenia codes  
Code  Description 
F20  Schizophrenia 
F21  Schizotypal disorder 
F23.1  Acute polymorphic psychotic disorder with symptoms of schizophrenia 
F23.2  Acute schizophrenia-like psychotic disorder 
F25.0  Schizoaffective disorders 
F25.1  Schizoaffective disorder, depressive type 
F25.2  Schizoaffective disorder, mixed type 
F25.8  Other schizoaffective disorders 
F25.9  Schizoaffective disorder, unspecified 
Same hospital readmissions within 30 days for/among patients 
discharged with bipolar disorder (readmission rate and number of 
readmission) 
Numerator: Total number of unplanned readmissions in a calendar year to the same hospital 
for patients (aged 15 and over) separated from hospital at least once in the referred year with 
a principal diagnosis of one of the selected mental health conditions (Table B.14).  
Denominator: Total number of patients (aged 15 and over) separated at least once from 
hospital in the referred year with a principal or first two listed additional diagnosis of 
bipolar disorder (Table B.16).  
Exclusions: 
• same-day separations are excluded from both the numerator and the denominator. 
Table B.16: ICD-10 (WHO and AM) bipolar disorder codes  
Code Description 
F31  Bipolar affective disorder 
B.4 Cancer care indicators 
ICD-10-WHO codes as supplied in the HCQI specs were found to be adequate to describe 
the specified diseases in the ACD, therefore no mappings were required. 
Breast cancer five-year relative survival 
Five-year observed survival for females aged 15–99 diagnosed with breast cancer (first 
primary cancer at the specified site) (ICD-10 code C50) divided by the expected survival of a 
comparable group from the general population (expressed in percentage). 
Cervical cancer five-year relative survival 
Five-year observed survival for females aged 15–99 diagnosed with cervical cancer (first 
primary cancer at the specified site) (ICD-10 code C53) divided by the expected survival of a 
comparable group from the general population (expressed in percentage). 
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Colorectal cancer five-year relative survival 
Five-year observed survival for males, females and total population aged 15–99 diagnosed 
with colorectal cancer (first primary cancer at the specified site) (ICD-10 codes: C18, C19, C20 
and C21) divided by the expected survival of a comparable group from the general 
population (expressed in percentage). 
B.5 Patient safety indicators 
Patient safety indicator specifications included codes in ICD-9-CM and ICD-10-WHO. The 
AIHW mapped these to ICD-10-AM and/or ACHI codes as appropriate, following the intent 
of the indicators where mapping was not straightforward. 
Retained surgical item or unretrieved device fragment 
Numerator: All separations with a code for Retained surgical item or unretrieved device fragment 
(Table B.17) in any additional diagnosis field among cases meeting the inclusion and 
exclusion rules for the denominator.  
Denominator: All surgical and medical separations aged 15 and over and for children aged 
0–14. 
Exclude cases:  
• with a code for retained surgical item or unretrieved device fragment in the principal 
diagnosis field 
• same-day separations are excluded from both the numerator and the denominator 
• for children aged less than 15 years, also exclude normal newborns and newborns 
weighing less than 500 grams. 
Table B.17: ICD-10 (WHO and AM) retained surgical item or unretrieved device fragment codes 
Code Description 
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure 
T81.6 Acute reaction to foreign substance accidentally left during a procedure 
Y61.0 Foreign object accidentally left in body during surgical and medical care: During surgical operation 
Y61.1 Foreign object accidentally left in body during surgical and medical care: During infusion or transfusion 
Y61.2 Foreign object accidentally left in body during surgical and medical care: During kidney dialysis or other perfusion 
Y61.3 Foreign object accidentally left in body during surgical and medical care: During injection or immunisation 
Y61.4 Foreign object accidentally left in body during surgical and medical care: During endoscopic examination 
Y61.5 Foreign object accidentally left in body during surgical and medical care: During heart catheterization 
Y61.6 Foreign object accidentally left in body during surgical and medical care: During aspiration, puncture and other 
catheterization 
Y61.7 Foreign object accidentally left in body during surgical and medical care: During removal of catheter or packing 
Y61.8 Foreign object accidentally left in body during surgical and medical care: During other surgical and medical care 
Y61.9 Foreign object accidentally left in body during surgical and medical care: During unspecified surgical and medical care 
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Postoperative haemorrhage or haematoma 
Mapping of the procedure codes from ICD-9-CM to ACHI for postoperative control of 
haemorrhage or drainage of haematoma was not a straightforward process but the intent of 
indicator was followed to give the most complete list possible.  
Numerator: Separations among cases defined in the denominator with ICD code for 
postoperative haemorrhage or haematoma (Table B.18) in any additional field and procedure 
code for postoperative control of haemorrhage or drainage of haematoma (Table B.19). 
Denominator: 
All surgical separations with a code for an operating room procedure, for patients aged 15 
and over and for children aged 0–14. 
Exclude cases: 
• with principal diagnosis of postoperative haemorrhage or postoperative haematoma. 
(The specifications ask that additional diagnosis of postoperative haemorrhage or 
postoperative haematoma present on admission also be excluded if known, but this was 
not possible for Australian data.) 
• where the only operating room procedure is postoperative control of haemorrhage or 
drainage of haematoma 
• where a procedure for postoperative control of haemorrhage or drainage of haematoma 
occurs before the first operating room procedure. (This exclusion could not be 
implemented by the AIHW.) 
• principal diagnosis of pregnancy, childbirth and puerperium  
• for children aged less than 15 years old, also exclude newborns weighing less than 500 
grams. 
Table B.18: ICD-10 (WHO and AM) postoperative haemorrhage or haematoma code  
Code Description 
T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified 
Table B.19: Postoperative control of haemorrhage or for drainage of haematoma code map 
ICD-9-CM ACHI 7th 
edition 
Block no. Description 
287 Control of haemorrhage after 
tonsillectomy and adenoidectomy 
41797-00 410 Arrest of haemorrhage following tonsillectomy and 
adenoidectomy 
3880 Other surgical occlusion of unspecified 
site 
34106-14 697 Interruption of other artery 
  34106-19 726 Interruption of other vein 
  37420-00 1195 Ligation of vein to inhibit rapid penile drainage 
3881 Other surgical occlusion of intracranial 
vessels 
No map     
3882 Other surgical occlusion of other vessels 
of head and neck 
34100-02 697 Interruption of carotid artery 
  34100-03 726 Interruption of jugular vein 
  52141-00 697 Interruption of mandibular artery 
 (continued) 
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Table B.19 (continued): Postoperative control of haemorrhage or for drainage of haematoma code 
map 
ICD-9-CM ACHI 7th 
edition 
Block no. Description 
  52141-01 697 Interruption of facial artery  
  52141-02 697 Interruption of lingual artery 
  52141-03 726 Interruption of facial vein 
  52141-04 726 Interruption of lingual vein 
  52141-05 726 Interruption of mandibular vein 
3883 Other surgical occlusion of upper limb 
vessels 
34103-11 697 Interruption of axillary artery 
  34103-16 726 Interruption of axillary vein 
  34106-10 697 Interruption of brachial artery 
  34106-11 697 Interruption of radial artery 
  34106-12 697 Interruption of ulnar artery 
  34106-15 726 Interruption of brachial vein 
  34106-16 726 Interruption of radial vein 
  34106-17 726 Interruption of ulnar vein 
3884 Other surgical occlusion of aorta, 
abdominal 
No map     
3885 
Other surgical occlusion of thoracic 
vessel 34103-10 697 Interruption of subclavian artery 
  34103-15 726 Interruption of subclavian vein 
  38700-01 690 Closure of patent ductus arteriosus 
  38715-00 717 Banding of main pulmonary artery 
3886 Other surgical occlusion of abdominal 
arteries 
34103-12 697 Interruption of iliac artery 
3887 Other surgical occlusion of abdominal 
veins 
34103-17 726 Interruption of iliac vein 
3888 Other surgical occlusion of lower limb 
arteries 
34103-13 697 Interruption of femoral artery 
  34103-14 697 Interruption of popliteal artery 
  34106-13 697 Interruption of tibial artery 
3889 Other surgical occlusion of lower limb 
veins 
34103-18 726 Interruption of femoral vein 
  34103-19 726 Interruption of popliteal vein 
  34106-18 726 Interruption of tibial vein 
3941 Control of haemorrhage following 
vascular surgery 
33842-00 698 Control of postoperative bleeding or thrombosis after 
carotid or vertebral artery surgery 
  33845-00 746 Control of postoperative bleeding or thrombosis after 
intra-abdominal vascular procedure 
  33848-00 746 Control of postoperative bleeding or thrombosis of an 
extremity after vascular procedure 
3998 Control of haemorrhage nos 30058-01 777 Control of postoperative haemorrhage, not elsewhere 
classified 
 (continued) 
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Table B.19 (continued): Postoperative control of haemorrhage or for drainage of haematoma code 
map 
ICD-9-CM ACHI 7th 
edition 
Block no. Description 
  30663-00 1195 Control of haemorrhage following male circumcision 
  35759-00 1299 Control of postoperative haemorrhage, following 
gynaecological surgery NEC 
  38656-01 562 Reopening of thoracotomy or sternotomy site 
4995 Control of (postoperative) haemorrhage 
of anus 
90345-00 931 Control of haemorrhage of rectum or anus 
5793 Control of (postoperative haemorrhage 
of bladder 
36842-00 1092 Endoscopic lavage of blood clots from bladder 
6094 Control of (postoperative) haemorrhage 
of prostate 
90392-00 1162 Control of postoperative haemorrhage of prostate 
1809 Other incision of external ear No map     
540 Incision of abdominal wall 13112-00 1062 Establishment of peritoneal dialysis by abdominal 
puncture and insertion of temporary catheter 
  30402-00 987 Drainage of retroperitoneal abscess 
  37812-00 1178 Exploration of groin for impalpable testis 
  90952-00 987 Incision of abdominal wall 
5412 Reopening of recent laparotomy site 30385-00 985 Postoperative reopening of laparotomy site 
  30397-00 987 Laparostomy via previous surgical wound 
  90375-01 983 Replacement of intra-abdominal packing 
  90375-02 983 Removal of intra-abdominal packing 
5919 Other incision of perivesicle tissue 90369-00 1127 Exploration of perivesical tissue 
610 Incision and drainage of scrotum and 
tunica and vaginalis 
37604-00 1172 Exploration of scrotal contents, unilateral 
  37604-01 1172 Exploration of scrotal contents, bilateral 
6998 Other operations on supporting 
structures of uterus 
35680-00 1272 Laparoscopic reconstruction of uterus and supporting 
structures 
7014 Other vaginotomy 35572-01 1280 Vaginotomy 
7109 Other incision of vulva and perineum 35569-00 1287 Enlargement of vaginal orifice 
7591 Evacuation of obstetrical incisional 
haematoma of perineum 
90484-00 1347 Evacuation of perineal incisional haematoma 
7592 Evacuation of other haematoma of vulva 
or vagina 
90484-01 1347 Evacuation of nonincisional haematoma of perineum 
or vagina 
8604 Other incision w/ drainage of skin and 
subcutaneous tissue 
30223-00 1606 Incision and drainage of haematoma of skin and 
subcutaneous tissue 
  30223-01 1606 Incision and drainage of abscess of skin and 
subcutaneous tissue 
  30223-02 1606 Other incision and drainage of skin and subcutaneous 
tissue 
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Postoperative wound dehiscence 
Numerator: Separations among cases defined in the denominator with procedure code for 
reclosure of postoperative disruption of abdominal wall (ICD-9-CM code: 5461, Reclosure 
postoperative disruption mapped to ACHI code: 3040303, Reclosure of postoperative disruption of 
abdominal wall). 
Denominator: All abdominopelvic surgical separations, for patients aged 15 and over and 
for children aged 0–14. 
Exclude cases: 
• where a procedure for reclosure of postoperative disruption of abdominal wall occurs 
before or on the same day as the first abdominopelvic surgery procedure. (This exclusion 
could not be implemented by the AIHW) 
• where length of stay is less than 2 days 
• principal diagnosis of pregnancy, childbirth and puerperium 
• with any diagnosis or procedure code for immunocompromised state 
• for children aged less than 15 years old, also exclude: 
– with hepatic failure consisting of any diagnosis of cirrhosis and any diagnosis of 
hepatic coma or hepatorenal syndrome 
– with procedure code for gastroschisis or umbililcal hernia repair in newborns 
(omphalacele repair) performed before reclosure. (Exclusion of those procedures that 
were performed before reclosure could not be implemented by the AIHW.) 
– newborns weighing less than 500 grams. 
Postoperative pulmonary embolism or deep vein thrombosis  
Numerator: Separations among cases meeting the inclusion and exclusion rules for the 
denominator with ICD codes for deep vein thrombosis or pulmonary embolism (Table B.20) 
in any additional diagnosis field.  
Denominator: Surgical separations (aged 15 and over) with a code for an operating room 
procedure for a) all surgical separations (code list can be obtained by contacting the AIHW) 
and b) hip and knee replacement separations (Table B.21). 
Exclude cases:  
• with principal diagnosis of deep vein thrombosis or pulmonary embolism (The 
specifications ask that additional diagnosis of deep vein thrombosis or pulmonary 
embolism present on admission also be excluded if known, but this was not possible for 
Australian data) 
• where a procedure for interruption of vena cava is the only operating room procedure  
• where a procedure for interruption of vena cava occurs before or on the same day as the 
first/main operating room procedure. (This exclusion could not be implemented by the 
AIHW. Note that if day of procedure is not available in the input data file, the rate may 
be slightly lower than if the information was available.) 
• principal diagnosis of pregnancy, childbirth and puerperium  
• with length of stay less than 2 days.  
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Table B.20: ICD-10 (WHO and AM) pulmonary embolism and  
deep vein thrombosis diagnosis codes  
Code Description 
I26.0   Pulmonary embolism with mention of acute cor pulmonale  
I26.9   Pulmonary embolism without mention of acute cor pulmonale  
I80.1   Phlebitis and thrombophlebitis of femoral vein  
I80.2   Phlebitis and thrombophlebitis of other deep vessels of lower extremities  
I80.3   Phlebitis and thrombophlebitis of lower extremities, unspecified  
I80.8   Phlebitis and thrombophlebitis of other sites  
I80.9   Phlebitis and thrombophlebitis of unspecified site  
I82.8   Embolism and thrombosis of other specified veins  
I82.9   Embolism and thrombosis of unspecified vein  
 
Table B.21: Total hip and knee replacement procedure code map 
ICD-9-CM ACHI 7th ed Block Decription 
8151  Total hip replacement 4931800 1489 Total arthroplasty of hip, unilateral 
  4931900 1489 Total arthroplasty of hip, bilateral 
  9060700 1489 Resurfacing of hip, unilateral 
  9060701 1489 Resurfacing of hip, bilateral 
8154 Total knee replacement 4951700 1518 Hemiarthroplasty of knee 
  4951800 1518 Total arthroplasty of knee, unilateral 
  4951900 1518 Total arthroplasty of knee, bilateral 
  4952100 1519 
Total arthroplasty of knee with bone graft to femur, 
unilateral 
  4952101 1519 
Total arthroplasty to knee with bone graft to femur, 
bilateral 
  4952102 1519 
Total arthroplasty to knee with bone graft to tibia, 
unilateral 
  4952103 1519 
Total arthroplasty to knee with bone graft to tibia, 
bilateral 
  4952400 1519 
Total arthroplasty of knee with bone graft to femur 
and tibia, unilateral 
  4952401 1519 
Total arthroplasty of knee with bone graft to femur 
and tibia, bilateral 
  4953401 1518 
Total replacement arthroplasty of patellofemoral joint 
of knee 
  9056200 1524 Patella resurfacing 
Postoperative sepsis  
Numerator: Separations among cases meeting the inclusion and exclusion rules for the 
denominator with a code for sepsis (Table B.22) in any additional diagnosis field.  
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Denominator: Surgical separations (aged 15 and over) with a code for an operating room 
procedure for a) all surgical separations and b) abdominopelvic surgical separations. (These 
code lists can be obtained by contacting the AIHW.) 
Exclude cases:  
• with a principal diagnosis of sepsis or infection. (The specifications ask that additional 
diagnosis of sepsis or infection present on admission also be excluded if known, but this 
was not possible for Australian data.) 
• with a principal diagnosis of infection, or any code for immunocompromised state, or 
cancer  
• principal diagnosis of pregnancy, childbirth and puerperium  
• with length of stay of less than 3 days.  
Table B.22: ICD-10 Sepsis diagnosis code map  
ICD-10-WHO  ICD-10-AM 7th edition 
A40.0 Septicaemia due to streptococcus, group a A40.0 Sepsis due to streptococcus, group A 
A40.1 Septicaemia due to streptococcus, group b A40.1 Sepsis due to streptococcus, group B 
A40.2 Septicaemia due to streptococcus, group d A40.2 Sepsis due to streptococcus, group D 
A40.3 Septicaemia due to streptococcus pneumoniae A40.3 Sepsis due to Streptococcus pneumoniae 
A40.8 Other streptococcal septicaemia A40.8 Other streptococcal sepsis 
A40.9 Streptococcal septicaemia, unspecified A40.9 Streptococcal sepsis, unspecified 
A41.0 Septicaemia due to staphylococcus aureus A41.0 Sepsis due to Staphylococcus aureus 
A41.1 Septicaemia due to other specified 
staphylococcus 
A41.1 Sepsis due to other specified staphylococcus 
A41.2 Septicaemia due to unspecified staphylococcus A41.2 Sepsis due to unspecified staphylococcus 
A41.3 Septicaemia due to haemophilus influenza A41.3 Sepsis due to Haemophilus influenzae 
A41.4 Septicaemia due to anaerobes A41.4 Sepsis due to anaerobes 
A41.5 Septicaemia due to other gram-negative 
organisms 
A41.5 Sepsis due to other and unspecified Gram-negative 
organisms 
  A41.50 Sepsis due to unspecified Gram-negative organisms 
  A41.51 Sepsis due to Escherichia coli [E. Coli] 
  A41.52 Sepsis due to Pseudomonas 
  A41.58 Sepsis due to other Gram-negative organisms 
A41.8 Other specified septicaemia A41.8 Other specified sepsis 
A41.9 Septicaemia, unspecified A41.9 Sepsis, unspecified 
R57.2 Septic shock R57.2 Septic shock 
R57.8 Other shock R57.8 Other shock 
R65.0 Systemic Inflammatory Response Syndrome of 
infectious origin without organ failure 
R65.0 Systemic inflammatory response syndrome [SIRS] 
of infectious origin without acute organ failure 
R65.1 Systemic Inflammatory Response Syndrome of 
infectious origin with organ failure 
R65.1 Systemic inflammatory response syndrome [SIRS] 
of infectious origin with acute organ failure 
T81.1 Shock during or resulting from a procedure, not 
elsewhere classified 
T81.1 Shock during or resulting from a procedure, not 
elsewhere classified 
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Accidental puncture or laceration 
Numerator: Separations among cases meeting the inclusion and exclusion rules for the 
denominator with code denoting accidental cut, puncture, perforation or laceration during a 
procedure (Table B.23) in any additional diagnosis field.  
Denominator: All surgical and medical separations. (These code lists can be obtained by 
contacting the AIHW.) Disaggregated by patients aged 15 and over and children aged 0–14. 
Exclude cases: 
• with code denoting technical difficulty (for example, accidental cut, puncture, 
perforation or laceration) in the principal diagnosis field. (The specifications ask that 
additional diagnosis code denoting technical difficulty present on admission also be 
excluded if known, but this was not possible for Australian data.) 
• principal diagnosis of pregnancy, childbirth, and puerperium  
• same-day separations  
• for children aged less than 15 years old, also exclude normal newborns and newborns 
weighing less than 500 grams 
• with procedure codes for spine surgery. 
Table B.23: ICD-10 (WHO and AM) accidental puncture or laceration diagnosis codes  
Code Description 
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified 
Y60.0 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during surgical operation 
Y60.1 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during infusion or 
transfusion 
Y60.2 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during kidney dialysis or 
other perfusion 
Y60.3 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during injection or 
immunization 
Y60.4 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during endoscopic 
examination 
Y60.5 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during heart 
catheterization 
Y60.6 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during aspiration, puncture 
and other catheterization 
Y60.7 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during administration of 
enema 
Y60.8 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during other surgical and 
medical care 
Y60.9 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care: during unspecified surgical 
and medical care 
Obstetric trauma 
Includes: Vaginal delivery separations for patients aged 15 and over. Codes for delivery 
outcome differ somewhat in ICD-10-AM and ICD-10-WHO and therefore a map was not 
attempted. Instead a new list following the intent of the indicator was developed 
(Table B.24). 
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Table B.24: ICD-10-AM outcome of delivery codes 
ICD-10-AM  
O80 Single spontaneous delivery 
O81 Single delivery by forceps and vacuum extractor 
O83 Other assisted single delivery 
O84 Multiple delivery 
O84.0 Multiple delivery, all spontaneous 
O84.1 Multiple delivery, all by forceps and vacuum extractor 
O84.8 Other multiple delivery 
O84.81 Multiple delivery, all assisted, not elsewhere classified 
O84.82 Multiple delivery by combination of methods 
O84.9 Multiple delivery, unspecified 
Vaginal delivery with instrument 
Numerator: Separations among cases meeting the inclusion and rules for the denominator 
with codes for third and fourth degree obstetric trauma in any diagnosis (Table B.25). (In 
following the intent of the indicator the AIHW also included cases with ACHI code 16573-00, 
suture of third or fourth degree tear of perineum, in a procedure field.) 
Denominator: All vaginal delivery separations (Table B.24) with any procedure code for 
instrument-assisted delivery (Table B.26) for patients aged 15 and over. 
Table B.25: ICD-10 (WHO and AM) obstetric trauma diagnosis codes  
Code Description 
O70.2  Third degree perineal laceration during delivery  
O70.3  Fourth degree perineal laceration during delivery  
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Table B.26: Instrument-assisted delivery procedure code map  
ICD-9-CM  ACHI 8th 
edition 
Block Description 
720 Low forceps operation 9046800 1337 Low forceps delivery 
721 Low forceps operation w/ episiotomy       
724 Forceps rotation of fetal head 9046803 1337 Forceps rotation of fetal head 
  9046804 1337 Forceps rotation of fetal head with delivery 
726 Forceps application to aftercoming head       
728 Other specified instrumental delivery       
729 Unspecified instrumental delivery       
7221 Mid forceps operation w/ episiotomy       
7229 Other mid forceps operation 9046801 1337 Mid-cavity forceps delivery 
7231 High forceps operation w/ episiotomy       
7239 Other high forceps operation 9046802 1337 High forceps delivery 
7251 Partial breech extraction w/ forceps to 
aftercoming head 
9047002 1339 Assisted breech delivery with forceps to 
after-coming head 
7253 Total breech extraction w/ forceps to 
aftercoming head 
9047004 1339 Breech extraction with forceps to after-coming 
head 
7271 Vacuum extraction w/ episiotomy       
7279 Vacuum extraction delivery nec 9046900 1338 Vacuum extraction with delivery 
  9046901 1338 Failed vacuum extraction 
  9046805 1337 Failed forceps 
  9047001 1339 Assisted breech delivery 
  9047200 1343 Episiotomy 
  9047400 1343 Incision of cervix to assist delivery 
  9047500  Symphysiotomy to assist delivery 
Vaginal delivery without instrument  
Numerator: Separations among cases meeting the inclusion and exclusion rules for the 
denominator with codes for third and fourth degree obstetric trauma in any diagnosis (Table 
B.25). (In following the intent of the indicator the AIHW also included cases with ACHI code 
16573-00, suture of third or fourth degree tear of perineum, in a procedure field.) 
Denominator: All vaginal delivery separations (Table B.24) for patients aged 15 and over.  
Exclude cases:  
• with instrument-assisted delivery (Table B.26).  
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Glossary 
Most definitions in this glossary contain an identification number from the METeOR. 
METeOR is Australia’s central repository for health, community services and housing 
assistance metadata, or ‘data about data’. It provides definitions for data for topics related to 
health and community services, and specifications for related NMDSs. METeOR can be 
viewed on the AIHW website at <www.aihw.gov.au>. 
Additional diagnoses: A condition or complaint either coexisting with the principal 
diagnosis or arising during the episode of care. This is equivalent to the OECD HCQI 
concept of secondary diagnosis. METeOR identifier: 391322. 
Age standardisation: A set of techniques used to remove, as far as possible, the effects of 
differences in age when comparing two or more populations. 
Australian Classification of Health Interventions (ACHI): The 6th edition was used for the  
2008–09 and 2009–10 procedures data for admitted patients in Australian hospitals. The 7th 
edition was used for the 2011–12 procedures data for admitted patients in Australian 
hospitals. METeOR identifier: 514008 
Episode of care: The period of admitted patient care between a formal or statistical 
admission and a formal or statistical separation, characterised by only one care type (see 
Separation). METeOR identifier: 270174 (Care type), METeOR identifier: 268956 (Episode of 
admitted patient care). 
Hospital: A health-care facility established under Commonwealth, state or territory 
legislation as a hospital or a free-standing day procedure unit and authorised to provide 
treatment and/or care to patients. METeOR identifier: 268971. 
International Classification of Diseases (ICD): The World Health Organization’s 
internationally accepted classification of diseases and related health conditions. The 10th 
revision, Australian modification (ICD-10-AM) is currently in use in Australian hospitals for 
admitted patients. Data for 2010–11 and 2011–12 were reported to the NHMD using the 7th 
edition of ICD-10-AM, 2008–09 and 2009–10 data used the 6th edition and 2007–08 used the 
5th edition. METeOR identifier: 514003 
Length of stay: For an overnight patient, calculated by subtracting the date the patient is 
admitted from the date of separation and deducting days the patient was on leave. A  
same-day patient is allocated a length of stay of one day. METeOR identifier: 269982. 
Performance indicator: A statistic or other unit of information that reflects, directly or 
indirectly, the extent to which an expected outcome is achieved or the quality of processes 
leading to that outcome.  
Potentially preventable hospitalisation (selected): Those conditions where hospitalisation is 
thought to be avoidable if timely and adequate non-hospital care is provided.  
Principal diagnosis: The diagnosis established after study to be chiefly responsible for 
occasioning an episode of admitted patient care. METeOR identifier: 391326. 
Private hospital: A privately owned and operated institution, catering for patients who are 
treated by a doctor of their own choice. Patients are charged fees for accommodation and 
other services provided by the hospital and relevant medical and paramedical practitioners. 
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Acute care and psychiatric hospitals are included, as are private free-standing day hospital 
facilities.  
Procedure: A clinical intervention that is surgical in nature, carries a procedural risk, carries 
an anaesthetic risk, requires specialised training and/or requires special facilities or 
equipment available only in the acute-care setting. METeOR identifier: 391349. 
Public hospital: A hospital controlled by a state or territory health authority. Public 
hospitals offer free diagnostic services, treatment, care and accommodation to all eligible 
patients. 
Separation: An episode of care for an admitted patient, which can be a total hospital stay 
(from admission to discharge, transfer or death) or a portion of a hospital stay beginning or 
ending in a change of type of care (for example, from acute to rehabilitation). Separation also 
means the process by which an admitted patient completes an episode of care either by being 
discharged, dying, transferring to another hospital or changing type of care. The OECD 
HCQIs refer to admissions; however, Australia’s data is for separations. 
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